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ABSTRACT

GENE THERAPY AND CELLULAR TRANSPLANTATION: TOWARDS A
COMBINATION STRATEGY FOR SPINAL CORD INJURY REPAIR

Ahmed A. Abdellatif
November, 30 2007

The combination of viral mediated gene delivery, tissue engineering, and
Schwam1 cell (SC) transplantation offer a promising strategy to enhance axonal
regeneration and functional recovery following spinal cord injury (SCI). The rationale
and feasibility of using such combination has been extensively reviewed in Chapter I.
The study presented in Chapter 2 showed that lentiviral vectors are most suitahle
in situations where stable long term transgene expression is needed, while adenovirus and
retrovirus are more suited for transient gene delivcry.
Tissue engineering combined with Schwann cell (SC) transplantation is a
promising method to enhance regeneration and remyelination ofaxons following a
thoracic spinal cord injury (SCI). Previously, SCs in semi-permeable guidance channels
made of polyacrylonitrile and polyvinylchloride (PAN/PVC) copolymers were shown to
promote the growth ofaxons into the graft environment. In Chapter 3, we test whether
different PAN/PVC mini-channel geometries affects axonal regeneration, we compared
three types of channels, i.e. channels with smooth inner wall, channels with grooved

v

inner wall, and channels filled with filaments using this model. Our results showed that
grooving of the channel inner wall along the axis of the channel resulted in a significantly
higher number (730.66±252.76) of myelinated axons at the channel mid-point, compared
to the channels with smooth inner wall (539.4±287.63; p<O.OI), indicating an
enhancement of axonal regeneration when grooves are provided within the channel.

[n

contrast, channels filled with filaments had a significantly lower number of myelinated
axons (l63.54±76.04) than both the grooved and smooth inner wall channels (p<O.OOI),
indicating that densely-packed filaments prohibited axonal growth into the channel. This
type of channels may need to be modified to incorporate growth-promoting molecules on
filament surface and/or decrease the number of filaments inside the channel to provide
attractiveness and/or space for more axons to grow. We conclude that the use of channels
with grooved inner wall, combination with seeded SCs, is more suitable for axonal
regeneration and myelination following SCI than the other two channel types. This
combination can be used in further studies with the addition of regeneration enhancing
factors such as neurotrophins.

In Chapter 4, we examined axonal regeneration following transplantation of
PAN/PYC mini-channel seeded with SCs that were infected with 3 viral vectors, i.e.
retroviral, adenoviral, and lentiviral vectors. Although, animals in LZRS-D15A SCs
group had a significantly lower number of myelinated axons compared to lentiD15A
group they showed significant improvement in grid walking test. We conclude that
different patterns of transgene expression may enhance regeneration and myelination of
different populations of regenerating axons following thoracic SCI.

VI

In conclusion, combination strategies for SCI using different transgene expression
patterns and different channel inner wall geometry' enhance axonal regeneration and
myelination. Functional recovery however, may be the result of reorganization of spinal
cord circuitry rather than successful axonal regeneration.
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CHAPTER 1
INTRODUCTION

The earliest recorded evidence of spinal cord injury (SCI) is from an Egyptian
text (Fig 1.1) written in 2500 B.C. (Breasted 1980) "When you examine a man with a
dislocation of a vertebra of his neck, and you find him unable to move his arms, and his
legs ... Then you have to say: a disease one cannot treat" (Case and Tessier-Lavigne
2005).
The first evidence of regenerative capacity in the spinal cord came in the early
1900s when Ramon y Cajal described "the cone of growth" in the injured spinal cord and
suggested that the absence of guiding factors is the reason behind their failure to
regenerate (Ramon y Cajal, 1952). An early recorded attempt at tissue transplantation to
treat human SCI came in 1944 when a St. Louis surgeon transplanted a piece of formalin
fixed cadaver spinal cord into the injured spinal cord of a 16y old male; he died three
months postoperative without any functional improvement (Woolsey 1944). To date,
spinal cord injured patients do not have a cure to their disability. Scientists at the
Kentucky Spinal Cord Injury Research Center (KSCIRC) as well as other researchers
worldwide are making steady steps towards the goal of bringing a cure to these patients.

Every year approximately 11,000 new cases of SCI are reported in the U.S. 82%
of which are males. The highest per capita rate of injury occurs between the ages of 1630 (National Spinal Cord Injury Association, and the National Spinal Cord Injury
Statistical Center, Birmingham, Alabama,
http://www.spinalcord.org/html/factsheets/spinstat.php). Currently, 200,000-400,000
people in the U.S. are living with SCI. These patients suffer from the consequences of
their injury resulting in dysfunction and loss of sensory, motor and autonomic function.
Patients with high level cervical injuries suffer more serious complications including fatal
respiratory and pressure ulcers. The work presented here focuses mainly on providing
axonal regeneration in a thoracic SCI in rat.

Anatomy of the Spinal Cord
The spinal cord de:velops from the caudal two thirds of the neural tube and
extends through the neural canal of the vertebral column. Its rostral end continues into the
medulla through the foramen magnum and the caudal end terminates in the conus
medullaris. The spinal cord has two enlargements: the cervical from C5 to Tl and the
lumbar from L I to S2. These enlargements are caused by the higher motor innervation
density for the limbs.
The spinal cord is arranged so that the central H-shaped gray matter is surrounded
by the spinal white matter comprised of the ascending and descending fibers of the spinal
tracts. The gray matter is grossly divided into dorsal horns, and ventral horns.
Histologically, it is divided into 9 Rexed laminae from dorsal to ventral, with the 10th
lamina surrounding the central canal of the spinal cord. Damage to the cervical
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enlargements and less commonly the lumbar enlargements also contributes to the deficit
that follows spinal cord injury.
The white matter is subdivided into three major funiculi: dorsal, ventral and
lateral. Spinal tracts are grouped into ascending sensory tracts: the posterior dorsal
column (gracile, and cuneate fasciculi), the anterolateral system (spinothalamic,
spinoreticular, spinomesencephalic, and spinotectal tracts), and the spinocerebellar
system (anterior, posterior and cuneo- cerebellar tracts). The descending motor system is
divided into: corticospinal, rubrospinal, tectospinal, reticulospinal and vestibulospinal
tracts. The disruption of these ascending and descending tracts as well as gray matter
leads to much of the disability encountered following SCI.
The spinal cord is supplied by longitudinal arterial trunks that receive segmental
arteries. Each segmental artery divides outside the spinal canal into 3 branches: the
anterior and posterior spinal canal arteries as well as the radicular artery which continues
along the nerve roots and divides into anterior and posterior radicular arteries. After
penetrating the dura mater, the anterior and posterior radicular arteries join the anterior
median longitudinal and the right and left posterolateral longitudinal spinal arteries.
Numerous anastomoses exist between these arteries forming the pial plexus (Mautes,
Weinzierl et al. 2000). Central arteries from the anterior median longitudinal arteries and
arterioles from the pial plexus form the intrinsic blood supply of the spinal cord. Large
anterior and posterior central veins collect venous blood and drain to the anterior and
posterior radicular veins.
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Pathology of Spinal Cord Injury
Trauma to the vertebral column results in distortion of the neural arch and
sudden narrowing of the vertebral canal. This results in compression, contusion and/or
tearing of the meninges and spinal cord tissue, with disruption of the blood supply and
breaching of the blood - spinal cord barrier (BSCB). The loss of sympathetic control
over the vascular system results in the life threatening "spinal shock" (Black and
Rossitch. 1995). Care for acute SCI patients is mainly directed at resuscitation,
stabilization of spinal fractures, and the control of spinal shock stage. Neurological
defects following SCI result primarily from damage of spinal tracts, disruption of
vascular supply and electrolyte imbalance (Tator 1998). Reports available on the
pathology of human SCI suggest that the rat contusion lesion (Metz, Curt et al. 2000) is
similar to a large number of human SCI (Kakul as 1988; Bunge, Puckett et al. 1993).

Experimental modelsfor SCI.
To replicate human SCI, researchers have developed multiple experimental SCI
models. The consensus is that these models have to be reliable, and reproducible, which
make it possible to predict outcomes and test possible therapeutic measures. These
models include contusion (Allen, D'Angelo et al. 1974; Basso, Beattie et al. 1996),
compression (Guth, Zhang et al. 1994), ischemia (Kanellopoulos, Kato et al. 1997), and
crush (Zhang and Guth 1997; Zhang, Krebs et al. 1997) injuries, which generate
controlled injuries that mimic some, but not all, clinical aspects of the mechanical
damage and posttraumatic ischemia that occur following human SCI. The transection
(Noble and Wrathall 1989) hemisection (Xu, Guenard et al. 1995; Xu, Chen et al. 1997;
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Xu, Zhang et al. 1999) model provides a controlled inj ury for unequivocally evaluating
axonal regeneration strategies. Hemisection provides an additional internal control in the
non-injured side of the cord. However, these later injuries share little pathological
relevance to the majority of human SCI.
The immediate events following traumatic contusion/compression experimental
SCI models are intraparenchymal hemorrhage and vasospasm of spinal arteries, which
start in the most vulnerable spinal gray matter (Ducker and Hamit 1969). The disruption
of blood vessels following trauma leads to loss of the BSCB with resulting edema,
infiltration of monocytes and macrophages, and release of cytokines leading to a decrease
of spinal tissue perfusion. This ischemia triggers cell death and excitotoxicity. Necrosis
and phagocytosis of dead spinal tissue typically leads to cavity formation and axonal
degeneration and demyelination. Recent data (Johnson, Taylor et al. 1995; Crowe,
Bresnahan et al. 1997; Liu, Xu et al. 1997; Beattie, Li et al. 2000; Beattie, Hermann et al.
2002; Beattie 2004) suggest that apoptosis of both neurons and glia also plays a important
role in the final pathologic picture.
Spinal cord injury research is geared towards reducing secondary injury following
an initial trauma including neuroprotection to preserve the intact spinal tissue and
preventing neuronal cell loss, as well as enhancing regeneration and myelination of
injured axons by particularly modifying the non-permissive environment at the injury
site.
Neurotrophic factors
Neurotrophic factors (NTFs) are molecules that have evolved in several gene
families and are important factors that influence the development, maintenance, function
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and plasticity of the nervous system. NTFs are made in the targets of dependant cells at
the tIme of innervation. The synthesis of these molecules is controlled such that the
transcription of mRNA is regulated during development and can be altered in adult
animals by injury and changes in neural activity (Heumann 1987; Lindholm 1994;
Lindholm, Castren et a1. 1994; Lindholm, da Penha Berzaghi et a1. 1994; Lindholm,
Harikka et a1. 1994; Lewin and Barde 1996). The survival of different neurons appears to
be dependent on multiple factors from the same family or from multiple families that can
be required sequentially or simultaneously (Oppenheim and Haverkamp 1988;
Oppenheim, Prevette et a1. 1991; Oppenheim, Yin et a1. 1992; Oppenheim, Prevette et a1.
1993; Snider 1994; Oppenheim, Houenou et a1. 2000). Some neurons appear to change
either their dependency from one factor to another during development (Davies 1994) or
their response to the same factor during different developmental stages. These changes
are due to receptor modification as well as changes in their downstream signaling
pathways. In neonatal (postnatal days P3 to PI 0) rats the spinal cord expresses higher
levels of nerve growth factor (NGF), brain derived neurotrophic factors (BDNF),
neurotrophin-3 (NT-3) and glial derived neurotrophic factor (GDNF) mRNA expression
and a lower level of ciliary neurotrophic factor (CNTF) when compared with the adult
normal spinal cord. In PIO-P17 neonatal rats, levels ofNGF, BDNF, NT-3 decreased
with a significant increase in CNTF mRNA levels. This shift ofNTFs expression in the
developing neonatal spinal cord indicates changing dependency (Nakamura and Bregman
2001). NTFs are believed to be retrogradely, as well as anterogradcly transported along
axons (Fawcett et a1. 2000). This transport may mediate local effects at synaptic sites, and
regulate dendritic growth, neuronal cytoarchitecture, and phenotypes (Altar, Cai et ai.
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1997; Fawcett 2002). The transport ofNT-3 for example has been found to be dependent
on extracellular sodium, intact microtubules and micro filaments, and requires the release
of calcium from intracellular stores (Wang, Reece et al. 2002)
The neurotrophins (NGF, BDNF, NT-3, NT-4/S and NT-6) bind, dimerize and
activate protein tyrosine kinases which subsequently act on substrates and signaling
pathways shared with other growth and differentiation factors. NGF binds TrkA, BDNF
and NT-4 bind TrkB, and NT-3 binds TrkC. These neurotrophins also bind to the low
affinity neurotrophin receptor p7S NTR that is closely related to the tumor necrosis factor
(TNF) receptor family (Bothwell 1995; Kaplan and Miller 1997). NT-3 gene ablation in
mice was found to cause a more severe phenotype than deletion of its receptor TrkC,
indicating that NT3 also acts through other receptors (Coppola, Kucera et al. 2001)
including TrkA, TrkB and the p7S NTR.
Neurotrophins regulate axon growth in vitro (Levi-Montalcini 1987) and target
tissue innervation in vivo (TSOUW1S, Soppet et al. 1993). Importantly they were found to
have protective effects on neurons in the CNS. NT-3 and BDNF play important roles in
the spinal cord both during development and post-SCI. BDNF promotes axonal
regeneration of spinal axons including local motor, sensory, and cerulospinal axons. NT3 enhances growth and sprouting of ascending sensory axons (Oudega and Hagg 1999).
Table 1.1 (Lu and Tuszynski 2007) shows the Sensitivity of spinal cord axons to different
growth factors. This information is very important in design of experiments targeting
specific axons following SCI. In our design we are using D15A a molecule with BDNF
and NT-3 activities, based on previous evidence we expect dorsal column sensory axons,
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rubrospinal axons, reticulospinal axons, vestibulospinal axons and local motor as well as
sensory axons to be responsive to D 15A neurotrophic activity.
Changes in NTFs levels have been shown following SCI both in the neonate and
adult spinal cords. As assessed by ribonuclease protection assay following SCI in the
adult rat, NGF and CNTF mRNA increased between 1-4 days, while BDNF and GDNF
transiently increased at 1 day post-injury. When compared to expression levels following
SCI injury in neonatal rats, BDNF mRNA was significantly lower and CNTF mRNA
significantly higher in adult rats indicating an important role of higher levels ofBDNF in
axonal regeneration following SCI in the early neonatal period (Nakamura and Bregman
2001). Following SCI, NT-3 were shown to influence collateral sprouting (Schnell,
Schneider et al. 1994; Weaver, Marsh et al. 2006).
Delivery of neurotrophins to the CNS has been studied using both ex vivo and in
vivo viral approaches. Genetically modified fibroblasts (Tuszynski, Grill et al. 2003),
astrocytes (Smith, Hale et al. 1996), stem cells (Falk, Holmstrom et al. 2002), SCs
(Menei, Montero-Menei et al. 1998; Tuszynski, Weidner et al. 1998), and olfactory
ensheathing cells (Ruitenberg, Plant et al. 2002; 2003) were transplanted into the spinal
cord to support axonal growth and regeneration. These studies have de:monstrated the
great potential of combining gene therapy with cellular grafts to enhance neuroprotection
and regeneration following SCI.

D15A Neurotrophin Molecule.
Mutational analysis of the interaction of Human NT-3 with its receptors TrkC and
p75 and the study of amino acid residues located on the surface ofNT-3 using alanine
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scanning mutagenesis defined the surface interaction ofNT-3 with TrkC and p75
(McDonald and Blundell 1991; Urfer, Tsoulfas et al. 1994). D15A, one of the NT-3
mutants developed by Urfer and colleagues (Urfer, Tsoulfas et al. 1994) was tested for
binding to TrkA, TrkB, and TrkC and found to bind firmly to TrkB, TrkC as well as the
p75 receptor. Further testing showed that D15A induced auto-phosphorylation on

PC12/TrkB cells that was similar to that achieved by BDNF. This indicated that D15A
had both NT-3 and BDNF activities.

The Schwann Cell

Peripheral nerves are composed of an outer epineurium of connective tissue,
fibroblasts and blood vessels, a perineurium of flattened cells surrounding nerve fascicles
and an endoneurium containing supporting cells and extracellular matrix molecules that
surround nerve fibers. The supporting tissue of the nerve includes SCs. Mature SCs are
elongated cells that extend longitudinally along axons of peripheral nerves, with a
centrally located oval nucleus. Two types of SCs exist. Myelinating SCs myelinate one
segment of an axon and ensheathing SCs surround and separate one or many
unmyelinated axons in longitudinal indentations along their surfaces. Each ensheathing
SC is associated with 5-20 axons, extending processes that create longitudinal furrows
that surround the axons' surface.
Peripheral nerve myelin is synthesized by SCs. Protein zero (Po), a member of
immunoglobulin gene family forms 80% of peripheral nerve myelin(Brunden,
Windebank et al. 1990). In peripheral nerve myelin, compaction of membrane surfaces
without intervening cytoplasm is accomplished solely by Po-Po interaction at both
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extracellular and intracellular surfaces (Giese, Martini et a1. 1992). In the CNS, DM-20
and proteolipid protein (PLP) serve a similar compaction function in the CNS (Agrawal
and Agrawal).
The analysis of early stages of migration of SCs and the formation of peripheral
nerves have lead to two hypotheses. The first one suggests that SC migration may
precede axonal elongation by up to 100 11m (Noakes and Bennett 1987). The second
hypothesis based on studies in chick limb innervation, suggests that motor axons pioneer
their pathway based on interactions with local cues and SCs follow immediately (Dahm
and Landmesser 1988; Carpenter and Hollyday 1992).
SCs play an active role in supporting neuronal outgrowth both during
development and after injury by providing NTFs such as NGF (Heumann 1987), BDNF
(Meyer, Matsuoka et a1. 1992) and platelet derived growth factor (PDGF) (Eccleston,
Collarini et a1. 1990) and CNTF (Friedman, Scherer et a1. 1992), as well as through
surface adhesive proteins (Bixby, Lilien et a1. 1988).
The interactions between Schwann cells (SCs) and neurotrophins are significant
in SC proliferation, migration, and myelination. BDNF enhances myelination in SCs
through p75 NTR and subsequently inhibits migration through the RhoAiRho kinase
pathway (Cosgaya, Chan et al. 2002; Yamauchi, Chan et a1. 2004). In contrast, NT-3
signaling in SCs enhanced cell migration and inhibited myelin formation via the fulllength TrkC receptor (Cosgaya, Chan et a1. 2002; Yamauchi, Chan et a1. 2(03). In vitro,
NT-3 levels were elevated during SC proliferation and migration and decreased during
myelination, whereas BDNF levels remained elevated throughout proliferation, migration
and myelination (Cosgaya, Chan et a1. 2002).
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Recent work demonstrated that SCs are a good candidate for cellular repair
strategies in SCI transplantation models (Bunge; Tuszynski and Gage; Xu, Guenard et al.
1995; Xu, Guenard et al. 1995; Xu, Chen et al. 1997; Xu, Zhang et al. 1999; Bamber, Li
et al. 2001; Iannotti, Li et al. 2003). Xu et al (Xu, Zhang et al. 1999) further developed
adult rat model of thoracic spinal cord hemisection and implantation of a PAN/PVC
mini-channel seeded with SCs. In this model SCs form an effective bridge that promotes
the in-growth of numerous myelinated and unmyelinated axons of both propriospinal and
supraspinal origins, some of these axons re-entered the distal spinal cord.
The combination of SC grafting and intraspinal infusion of BDNF and/or NT-3
following a lateral hemi-section lesion effectively promotes axonal outgrowth from a SC
seeded mini channel into the distal host spinal cord (Bamber, Li et al. 2001). Similarly,
infusion ofNT-3, BDNF and NGF successfully induced regeneration of sensory fibers
across a pre-degenerated nerve graft and into the thoracic: spinal cord in a dorsal column
lesion (Oudega and Hagg, 1999).

Tissue engineeringfor SCI repair
Several strategies for spinal cord regeneration have shown that axonal
regeneration can be enhanced using neurotrophins and/or blocking the inhibitory
molecules at the lesion site, leading to extension of these regenerating axons into the
lesion area. However, this is not organized axonal growth that leads to restoration of
function or a near normal arrangement ofaxons into axonal tracts as in the pre-injury
spinal cord.
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Axonal growth in vitro is controlled both chemically by cellular interaction
(Powell, Fawcett et al. 1997; Biran, Noble et al. 2003; Luo and Shoichet 2004) and
protein gradients (Miller, Jeftinija et al. 2002; Cao and Shoichet 2003) and physically by
substrate topography (Rajnicek and McCaig 1997; Miller, Jeftinija et al. 2(02). The
situation in vivo is rather complex, with many factors interfering with the regeneration
process including macrophage infiltration and glial scar formation.

Biomaterials can be molded into a three dimensional structure that have the
potential to provide support and guide axonal growth. These structures can be seeded
with a high concentration of cells and facilitate the formation of blood vessels once
implanted into the spinal cord. The principal function of the scaffold is to direct cell
migration, proliferation, differentiation (Zhang, Jin et al. 2005; Zhang, Yoo et al. 2005)
and axonal growth(Bakshi, Fisher et al. 2004; Stokols and Tuszynski 2(04). Therefore
the physical characteristics of biomaterial scaffold should include high porosity and large
surface area (Bhattarai, Bhattarai et al. 2004; Kidoaki, Kwon et al. 2(05). These 3-D
structures have been used in the form of a macroporous scaffold (Hurtado, Moon et al.
2006), a polymer foam conduit (Hadlock, Sundback et aL 2(00), or a mini-channel
seeded with SCs (Xu, Guenard et al. 1995; Xu, Guenard et al. 1995; 1997; 1999) in
peripheral nerve regeneration as well as in SCI.

Currently used biomaterials may be classified into two major categories; biodegradable and non-biodegradable. Bio-degradable materials include type I collagen
which has been successfully used as a gel (de la Torre 1982; Marchand, Woerly et al.
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1993), combined with NT -3 or BDNF (Houweling, Lankhorst et al. 1998; 1998) or with
SCs (Paino and Bunge 1991). Collagen gels were also injected in the subarachnoid space
to deliver growth factors to enhance the proliferation of endogenous stem cells in the
spinal cord (Jimenez Hamann, Tator et al. 2005). Although successful in peripheral
nerve repair (Sterne, Brown et al. 1997), fibronectin did not enhance axonal regeneration
even when combined with NT-3, NGF or BDNF (King, Lacey et al. 2004)" Other
biodegradable material were also used in SCI regeneration studies with variable success,
e.g. alginate/agarose (Stokols and Tuszynski 2004), hyaluronic acid (Rochkind, Shahar
et al. 2002), chitosan (Khor and Lim 2(03), poly-b-hydroxybutirate (Mohanna, Young
et al. 2003), poly glycolic/poly lactic (PGA/PLA) (Oudega, Gautier et al. 2001), poly
carbonate (Montgomery and Robson 1993), and polyethylene glycol (PEG) (Borgens,
Shi et al. 2002).

Non-biodegradable biomaterials used in SCI offer a major advantage of structural
stability over biodegradable materials. These include poly-hydroxymethyle methacrylate
(PHEMA/PHEMA-MMA) which were used successfully as porous tubes (Dalton, Flynn
et al. 2002) or as coil-reinforced channels to avoid collapse following implantation
(Katayama, Montenegro et al. 2006). Poly hydroxypropyl-methacrylamide (PHPMA) is
another material used for drug delivery and gene therapy applications (ProkopovaKubinova, Vargova et al. 2001; Parker 2005). It has also successfully induced axonal
regeneration and myelination after SCI when used as hydrogels (Woerly, Doan et al.
2004) or when combined with BDNF and CNTF in rat brain injury (Loh, Woerly et al.
2001).
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Poly acrylonitile-co-vinylchloride (PAN/PVC) is a structurally stable and non
toxic non-biodegradable biomaterial that has been used both in vivo and in vitro.
PAN/PVC has been successfully used by Xu and colleagues (Xu, Guenard et a1. 1995;
1995; 1997; 1999) in SCI both with SCs only or combined with neurotrophins. One
disadvantage of this material which limits its clinical applicability is the use of organic
solvents in the synthesis.

Combination strategy for SCI repair
Various approaches have been used to promote neuronal survival, axonal
regeneration, and recovery after injury. Transplantation of SCs demonstrated that CNS
neurons can regenerate for relatively long distances when a permissive environment is
provided (David and Aguayo 1981; Schnell and Schwab 1990). Semi-permeable
channels (Aebischer, Salessiotis et al. 1989) filled with purified primary SCs (Guenard,
Kleitman et al. 1992) implanted into injured rat spinal cord facilitate in-growth ofaxons
from sensory, motor, raphe nucleus, and brain stem neurons (Xu, Guenard et a1. 1995;
Guest, Klose et al. 1997; Xu, Chen et al. 1997).

SCs are widely accepted as having a great potential to enhance axonal
regeneration and myelination (Oudega and Xu 20(6). The aim of our work is to
characterize an effective combination strategy for SCI research, which includes a three
dimensional tissue bridge i.e. the PAN/PVC mini-channel seeded with SCs and
supplemented with the bi-functional neurotrophin D15A across the lesion gap, with a
gradient of an increasing concentration of neurotrophin to guide axons across the gap and
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back to the spinal cord tissue. We hypothesize that this combination will provide an
effective repair strategy for the injured axons to grow into and beyond the injury site. In
the first chapter, we characterized three viral delivery vectors in the spinal cord
environment. In chapter two we compare three types ofPAN/PVC channels. Our results
showed that, to create a gradient ofneurotrophin, one would optimally combine the short
expressing retrovirus with the longer expressing lentivirus.

The hemisection model we use gives us the ability to target all axons on one side
of the injured cord leaving the other side to serve as an internal control. The channel at
both interfaces faces the injured dorsal column, corticospinal tract, rubrospinal tract,
vestibulospinal tract, etc. thus all axons in ascending, descending and propriospinal tracts
can be studied in such a model.
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Table 1.1 Sensitivity of spinal cord axons to growth factors. (Lu and Tuszynski 2007)
Growth
factors

Injured axons

References

NGF

Nociceptive spinal axons

(Tuszynski, Peterson et al. 1994; Tuszynski,
Gabriel et al. 1996; Ramer, Priestley et al.)
(Tuszynski, Peterson et al. 1994; Tuszynski,
Gabriel et al. 1996)

Cerulospinal axons

BDNF

Rubrospinal axons
Raphespinal axons
Coerulospinal axons
Reticulospinal axons

(Kobayashi, Fan et al. 1997; Ye and Houle
1997; Liu, Kim et al. 1999)
(Bregman, McAtee et al. 1997)
(Menei, Montero-Menei et al. 1998)
(Menei, Montero-Menei et al. 1998)
(Ye and Houle 1997; Jin, Fischer et al. 2002)

Vestibulospinal
Local motor axon
Local sensory axon (CGRP)

(Jin, Fischer et al. 2002)
(Lu, Blesch et aL 2001)

Corticospinal axons

(Schnell, Schneider et al. 1994; Grill, Murai
et al. 1997)

Dorsal column sensory axons

(Bradbury, Khemani et al. 1999)

NT -4/5

Local motor axons
Coerulospinal axons
Reticulospinal axons
Propriospinal axons

(Blesch, Yang et al. 2004)

GDNF

Local motor axons
Propriospinal axons
Dorsal column sensory axons
Nociceptive spinal axons

(Blesch and Tuszynski 2003)

NT-3

(Ramer, Bradbury et al. 2003)
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Figure 1.1 The Edwin Smith surgical papyrus.

,
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CHAPTER 2

GENE DELIVERY TO THE SPINAL CORD: COMPARISON BETWEEN
LENTIVIRAL, ADENOVIRAL, AND RETROVIRAL VECTOR DELIVERY
SYSTEMS

INTRODUCTION

Axonal regeneration in the adult central nervous system (CNS) depends on a
critical balance between growth-promoting and -inhibiting cues (Chen, Huber et al.
2000). Neurotrophic factors have a potent survival, neuroprotective and growthpromoting activity on neurons both in vitro and in vivo (Davies 1994; Tobias, Shumsky
et al. 2003), making them an obvious therapeutic candidate for neurodegenerative and
traumatic disorders (Nagatsu 2002; Racine, Adams et al. 2002). The major obstacle for
the development of such therapies is the exclusion of the therapeutic molecule from the
CNS due to the selectivity of the blood-brain barrier (Pardridge 2002), as well as fast
plasma clearance (Dittrich, Ochs et al. 1996). Further, undesirable side effects of
systemic delivery ofneurotrophins have been shown (Tuszynski and Blesch 2004). To
avoid these side effects, direct delivery of neurotrophic factors into the CNS using
osmotic-pumps was employed (Olson, Nordberg et al. 1992). However, pump failure,
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variable stability, limited diffusion, and the risk of infection are possible complications
limiting the application of this approach (Oudega and Hagg 1996; Tan and Aebischer
1996).

Recent advances in molecular biology offer several possibilities for therapeutic
gene delivery including purified plasmids (Piccirillo and Prud'homme 2003), cationic
lipid-mediated delivery (FeIgner, Tsai et al. 1995), particle bombardment-mediated gene
transfer (gene gun) (Jiao, Cheng et al. 1993), receptor-mediated endocytosis (Chen,
Gamou et al. 1994), and antisense oligonucleotides (Tomita, Khan et al. 2004). These
non-viral methods have several advantages including safety, ease of synthesis!
modification, and unlimited transgene size. They are complicated, however, by
cytotoxicity, low efficiency, and limited target cell population (Tomita, Khan et al. 2004).
The use of viral vectors as an approach for gene therapy has been studied in many
CNS disorders including Parkinson's disease (Lundberg, Horellou et al. 1996),
Huntington's disease (Emerich, Lindner et al. 1996), Alzheimer's disease (Rosenberg,
Friedmann et al. 1988), and Tay-Sachs disease (Lacorazza, Flax et al. 1996). In spinal
cord injury (SC!), both ex vivo and in vivo approaches employing genetically modified
fibroblasts (Nakahara, Gage et al. 1996; Tuszynski, Grill et al. 2003), astrocytes (Smith,
Hale et al. 1996), and olfactory ensheathing cells (Ruitenberg, Plant et al. 2003) have
been used to deliver neurotrophic f:lctors to enhance neuronal survival, axonal growth,
and remyelination (McTigue, Homer et al. 1998; Tuszynski, Weidner et al. 1998).
Nonetheless, significant therapeutic efficacy is negated due to downregulation of
transgene activity soon after delivery (Andersen, Garber et al. 1992), vector cytotoxicity
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(Hermens and Verhaagen 1998), or host immune response di rected against the transgene
and viral proteins (Blomer, Naldini et al. 1996). Further, widespread acceptance of viral
vector-mediated gene therapy as a therapeutic tool in the treatment of CNS disease is
complicated by the unknown long-term safety of their usc.
In this study, we examined the temporal expression pattern of D 15A, a mutant
human NT-3 that binds TrkB and TrkC and has both BDNF and NT-3 activities, after its
viral-mediated delivery into the spinal cord (Urfer, Tsoulfas et al. 1994; Strohmaier,
Carter et aI. 1996; Cao, Xu et aI. 2(05), as well as the viral induced inflammatory
responses after lentiviral, adenoviral, and retroviral gene delivery in the spinal cord.

MATERIALS AND METHODS
Lentiviral Vector Production
The preparation and use of all viral vectors was carried out in bio-safety Level 2
laboratories with the approval of the Institutional Biosafety Committee of the University
of Louisville. We used a third generation lentiviral vector (Invitrogen, Carlsbad, CA; for
vector maps see www.invitrogen.com/content/sfs/vectors/plenti6v5dtopo map.pdf), that
was produced according to the manufacturer's instructions. Briefly, we utilized the
cDNA coding for D15A, a human NT-3 mutant that binds and activates both TrkB and
TrkC (Urfer, Tsoulfas et aI. 1994). A 780-bp fragment, containing a Kozak consensus
sequence was modified using PCR to include the sequence CACC at the 5 end. These
four nucleotides are complimentary to the overhang sequence GTGG in the pLenti6/V5D-Topo vector, a requirement for the Topo cloning reaction, the cloning site is located
downstream of a CMV promoter sequence. Viral particles were produced by transient
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transfection of 293FT cells (Naldini, Blomer et al. 1996) with the Virapower packaging
mix (Invitrogen) containing the following plasmids: pLPl (gag/pol), pLP2 (Rev),
pLP/VSVG, and pLenti6/V5D-Topo/DI5A, or pLenti6/V5-GW/LacZ. Forty-eight hours
after transfection, supernatants were collected and filtered. High-titer viral stocks were
obtained by ultracentrifugation at 16,000 rpm for 90 min and the pellet was re-suspended
in phosphate buffered saline (PBS) and virus stored at 80°C until use.

Adenoviral Vector Production
The cDNA encoding Dl5A was cloned into the Eldeleted Ad5CI-I-GFP (DI5A
expression is under CMV promoter control; vector maps are available at
www.stratagene.com/vectors/maps/pdf/pshuttle-IRES-hrGFP-I.pdD and replicationdeficient Ad5- D 15A adenovirus was isolated as described previously (Gao, Qu et al.
11

1998). The titer obtained was 1.1 x 10 transforming units (TU)/ml. Before surgery, virus
5

5

6

was diluted using PBS to either 1 x 10 , 5x 10 , or 1x 10 TU/I-.t1.

Retroviral Vector Production
The D15A cDNA was cloned into MSCV-I-GFP (provided by M.F. Roussel,
Dept. of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital,
Memphis, TN) and LZRSpBMN-I-GFP (kindly provided by G. Nolan, Stanford
University; for a map of the LZRSpBMN-I-GFP vector see
http://www.stanford.edu/group/nolan/) shuttle vectors. D15A expression in both MSCVI-GFP and LZR-SpBMN-I-GFP retroviruses is under the control of the 5 LTR. Viral
particles were produced by transient transfection of MSCV -I-G FP and VS V-G plasmids
into HEKl293 cells. Stable LZRSpBMN-I-GFP producer lines were obtained by
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transfection into <Dnx cells (Pear, Nolan et al. 1993; Pear 1997) and also provided by Dr.
Nolan. Media were collected, filtered, and viral titer quantified. Virus was concentrated
by ultracentrifugation as described previously (Bums, Friedmann et al. 1993).

Tetracycline-Inducible Retroviral System
Tet-inducible retrovims was produced according to the manufacturer's
instructions (Clontech, Palo Alto, CA; for vector maps see
http://orders.clontech.com/clontech/techinfol vectors/vectorsR-S/prevTRE.shtml).
Briefly, after cloning of the D15A cDNA into pRev-TRE vector in which Dl5A
expression is under the control of a minimal CMV promoter, the two-virus system was
produced by stably transfecting PT67 cells (NIH/3T3-based cell line expressing 10AI
viral envelope) with pRev-TRE- 0 15A to produce the first virus. PT67 cells were selected
with 0.2 mg/ml hygromycin for 7- 10 days. The regulator virus was produced by stably
transfecting PT67 cells with the pRevTet-On plasmid followed by G418 selection (0.4
mg/ml) for 5-7 days. Target cells used in the ex vivo experiment were infected with the

pRevTet-On virus and subjected to G418 selection (0.4 mg/ml) for 5-7 days, then
infected with pRev-TRE-D 15A virus and further subjected to hygromycin selection (0.2
mg/ml) for another 7- 10 days in vitro. Before doxycycline induction in vitro, the media

was changed to DMEM supplemented with tetracycline-free fetal bovine serum (FBS,
Clontech).

Determination of Viral Titer and Vector Bioactivity
To determine: the viral titer, a serial dilution of the viral stock was applied to 2 3
+

5

+

10 293T and NIH3T3 cells. The dilution that resulted in 15% or less GFP ILacZ cells
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after 48 hr was used for calculations. Lentivirus-D lSA titer was measured according to
the manufacturer's instructions; briefly, serial dilutions (lOto 10) of viral stocks were
5

applied to 2xlO NIH3T3 cells, 4 days later blasticidin 3 ~g/ml was added, and cells were
maintained for 10 days. Cells were washed in PBS and stained with crystal violet. Blue8

stained colonies were counted to determine the titer. Viral titers were routinely 1-3 x 10
5

TU/m!. Before surgery, virus stock was diluted with sterile saline to 1 x 10 TU/~l, S x
5

6

10 TU/J.d, or 1 x 10

TU/~l

for injection into the spinal cord. All viral vectors used for in

vivo delivery were matched for vollume and titer before delivery. All viral vectors used in
the ex vivo and in vitro experiments were matched for titer before use. Bioactivity in
conditioned media of infected NIH3T3 cells was tested by examining neurite outgrowth
(Fig. ID-F) from TrkC-expressing PC12 cells (Tsoulfas, Soppet et a!. 1993; Cao, Xu et
a!. 200S), recombinant human (rh) NT-3 was used to generate the standard curve.
Bioassay data were consistent with D1SA levels determined by ELISA (R&D Systems,
Minneapolis, MN).
NT-3 ELISA was carried out according to manufacturer's instructions. Briefly,
96-well microplates (Costar, Cambridge, MA) were coated with 100 ~l/well of
monoclonal mouse anti-NT-3 antibody (O.S J.tg/ml; R&D Systems) diluted in PBS buffer
overnight at room temperature. The plates were then incubated for 1 hr at room
temperature with blocking solution (1 % BSA in PBS). With interceding washes (O.OS%
Tween 20 in PBS, pH 7.4), the plates were subject to sequential 2 hr incubations at room
temperature with double aliquots of conditioned media, cell, and protein extracts from
spinal cords, or recombinant human NT-3 (rhNT-3; 0-2,000 pg/ml; R&D Systems),
biotinylated polyclonal goat anti-NT3 antibody (200 ng/ml; R&D Systems). The plates
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were then incubated sequentially for 20 min in Streptavidin-HRP (R&D Systems), and
1: 1 mixture ofH202 and tetramethylbenzidine (R&D Systems). The color reaction was

stopped (50 J.lllwell of2N H2S04; R&D Systems) and absorbance at 450 nm was
measured using a Molecular Devices Spectramax 384+ (Sunnyvale, CA). Using serial
dilutions of known amounts ofrhNT-3, this color reaction yielded a linear standard curve
from 62.5-2,000pg.

Preparation of Pur[J7ed Populations ofSchwann Cells
Schwann cells (SC) cultures were isolated as described (Morrissey, Kleitman et
a!. 1991; Xu, Zhang et a!. 1999). Briefly, sciatic nerves were dissected from adult rats
anaesthetized with pentobarbital sodium 40 mg/kg, J.P. After the epineurium and
connective tissue were removed, nerves were cut into 1 mm explants and placed in 35mm Coming tissue culture dishes (Baxter, Stone Mountain, GA) containing Dulbecco's
modified Eagle's medium (DMEM; Gibco, Grand Island, NY) supplemented with 10%
FBS. The explants were transferred to new culture dishes every 7 days with fresh
medium. After 3-5 weeks, explants were incubated overnight in dispase 1.25 U/ml
(Boehringer Mannheim Biochemicals, Indianapolis, IN), 0.05% collagenase
(Worthington Biochemicals Corp., Freehold, NJ) and 15% FBS in DMEM at
378Cin5(YoC02.The following day, explants were dissociated and cells were plated onto
poly-I-Iysine-coated 100 mm dishes in DMEM/IO% FBS, containing 20 mg/ml pituitary
extract (BTl, Stoughton, MA) and:2 mM forskolin (Sigma, St. Louis, MO).

Preparation and Transduction of Cells in Vitro
Other cell types used in the study (NIH/3T3, HEK 293FT, PT67, and <Dnx) were
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maintained in DMEM supplemented with 10% FBS. RN33B cells (Whittemore and
White 1993) were grown at 338C in DMEM/F12 supplemented with 5% FBS, and 250
Ilg/ml G418.
F or transduction of cells for in vitro viral experiments, cells were seeded into 65

well plates at a density of 10 cells/ well. Cells were pre-treated with 4-6 Ilg/ml
po1ybrene (Sigman, Poleski et al.) for 30-60 min (Manning, Hackett et al. 1971), then
infected for 6-8 hr at a multiplicity of infection (MOl) of 20, resulting in 80-90%
infection of the cells. Infection media were then replaced with fresh media. Forty-eight
hours later, conditioned media was collected for ELISA.

Surgical Procedures
A total of 150 adult, female, Sprague-Dawley rats (150-- 175 g) were housed 1 per
cage with free access to food and water under 12-hr light:dark cycle. All surgical
procedures were approved by and carried out according to the guidelines of the
Institutional Animal Care and Use Committee and the Institutional Biosafety Committee
at the University of Louisville. Animals were anesthetized with pentobarbital (40 mg/kg
IP) and placed into a stereotaxic frame (Kopf Instruments, Tujunga, CA). The spinal cord
was exposed with a laminectomy at the level ofT8, the dura incised to expose the cord,
5

5

and a total volume of 1 III of the viral stocks (1 x 10 or 5 x 10 TU), PBS, or cell
5

suspension (1 x 10 cell/Ill) was injected into the cord using a glass micro-pipette (outer
diameter 10-20 1m for viral infection and 25--40 1m for the cell suspension) attached to a

pico spritzer (Parker Instrumentation, Fairfield, NJ). Injections were made in the
ventrolateral white matter of the cord (1 Ill/injection) and the glass pipette remained in
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place for

2~3

min after injection. The incision was closed in layers. For host immune

modulation, we used transient immuno-blockade oflymphocytic cells by a combination
treatment of purified monoclonal antibodies against the rat CD4 and CD45 (OX-38 and
OX-22; Pharmingen, San Diego, CA) lymphocytic receptors. Animals in the adenovirus

+ mAb group received 50 Ilg (IP) of the: combined anti-sera 24 hr before and 24 hr after
the adenovirus administration (Romero and Smith 1998).

Tissue Processing
At I, 2, and 4 weeks after viral injection, the rats were anesthetized deeply with
pentobarbital and transcardially perfused with 200 ml 0.1 M phosphate buffer (PB) (pH =
7.4). For ELISA (n ==5/group), a I-cm segment of the spinal cord spanning the injection
site was removed, homogenized in lysis buffer (20 mM Tris-HCI pH 8.0, 137 mM NaCI,
1% NP40), and centrifuged at 10,000 rpm for

5~ 7

min at 48C to remove tissue debris.

Protein concentration in each sample was estimated using the Pierce BCA Protein Assay
(Pierce Chemical Co., Rockford, IL). Because D15A is a moditied NT-3 with antibody
binding epitopes preserved, a two-site NT-3 ELISA (R&D Systems) was used to
determine 0 15A levels in the samples.
For tissue prepared for immunohistochemistry (n = 51 group), PB perfusion was
followed by 250~300 ml of ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer (pH
7.4). A 1cm segment of the spinal cord spanning the injection site was removed and postfixed for 2 hr at 48°C, then transferred to 30% sucrose in 0.1 M PB for cryoprotection
until sectioned on a cryostat (Leica CM3050, Nussloch, Germany) at 20~25 1m and
mounted on microscope slides. The sections were rinsed in phosphate buffered saline
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(PBS), blocked, and pernleabilized in PBS containing 10% normal donkey serum (NOS)
and 0.3% Triton X-I 00 for I hr at room temperature, and incubated in primary antibody
overnight at 48C, with 5% NOS, and 0.25% Triton X-IOO in PBS. Polyclonal rabbit antiglial fibrillary acidic protein antibody (anti-GFAP; 1:100, Chemicon, Temecula, CA),
was used to identify astrocytes and monoclonal antibody adenomatous polyposis coli
(anti-APC) (I: 100; Oncogene, San Diego, CA) to identify oligodendrocytes. Monoclonal
antibody anti-NeuN (l: 100; Chemicon)" and polyclonal antibody anti-~III tubulin (l: 100;
Promega, Madison, WI) were used to identi(y neurons. Monoclonal antibodies anti-CD4
and anti-CD8 (I: 100; Pharmingen, San Diego, CA) were used to identify T lymphocytes.
Microglia (both ramified and reactive) and macrophages were stained using monoclonal
antibodies anti-OX-42 and anti-EDl (1 :500; Chemicon), respectively, as previously
described (Graeber, Banati et al. 1989; Koshinaga and Whittemore 1995). The next day,
sections were rinsed in PBS and incubated in either fluorescein-conjugated or rhodamineconjugated Fab fragment secondary antibodies from donkey (I: lOO; Jackson
Laboratories, Baltimore, MD). Slides were washed, mounted, and examined using a
Nikon TE300 fluorescent microscope and photographed with an Olympus Fluview
confocal microscope. Figures were assembled using Adobe® Photoshop and Illustrator
software (San Jose, CA).

Morphologic Analysis
+

To quantify the numbers of ED 1 macrophagcs, sections wcre analyzed using a
203 objective and the appropriate UV -filter on a Nikon E600 microscope. Starting from

the center of the injection, five sections from each animal over a distance of 2 mm were
+

examined and ED! cells were counted using Imagepro Plus software ® (Media
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Cybernetics, San Diego, CA) in an entire field.

Statistical Analysis
One-way ANOVA was used to compare control values with experimental groups
followed by Tukey's post-hoc comparison test. A P-value of <0.05 is considered
statistically significant.

RESULTS

In Vitro Infection Using Lentivirus, Adenovirus, and Retrovirus
Multiple cell lines were infected in vitro with various D 15A viral vectors to detect
the differences in gene expression levels between different viral delivery systems.
Infection efficiencies were 80-90% for all viruses as confirmed by
immunohistochemistry (Fig. 2.1). Table 2.1 shows that although similar MOl were used,
some differences in protein expression levels were noted. D 15A protein levels were
relatively higher after infection with both lentivirus (62-103-fold) and adenovirus (41175-fold) as compared to the two retroviruses LZRS (35-93-fold) and MSCV (35-53fold). This suggests that differences exist either in the cellular response to viral infection
or in internal regulation of gene expression between cells. Consistent with that
suggestion, retroviral expression was driven off the 5 LTR and the lentivirus and
adenovirus from the CMV promoter. Dl5A levels were significantly higher (P < 0.(01)
in the RN33B group than other viral groups tested or uninfected cells. There was no
statistically significant difference between the NIH3T3 cells and Schwann cells.
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Retrovirus Shows Rapid Downregulatioll of Transgene Expression A./ier Ex Vivo Delivery
Schwann cells were infected in vitro with matched MOI (20) using lentivirusD I SA, adenovirus-D 15A, retrovirus LZRS-D 15A, and retrovirus-EGFP. After
5

resllspension in culture media, I III containing I x 10 cells, with pre-injection viability of
90--95%, was injected into the thoracic spinal cord. Transgene expression was evaluated
at 1, 2, and 4 weeks (Fig. 2.2). There was no statistically signifilcant difference between
the normal cord and EGFP-infected Schwann cell grafted groups at all three time points.
The group that received lentiviraly infected Schwann cell grafts showed significantly
higher (P < 0.001) expression levels than normal cord, EGFP-, and LZRS-infected cells
at 1, 2, and 4 weeks, as well as adenovirally-infected cells at 4 weeks. There was no
significant difference between groups that received lentivirally-·infected and adenovirallyinfected Schwann cells at either 1 or 2 weeks post-grafting. In contrast, grafts of
adenovirally-infected Schwann cells showed some down-regulation over time, although
D 15A levels at 1 week were not significantly different from the: 2-week level in groups
that received both adcnovirally-infected and lentivirally-infected Schwann cells. At 4
weeks, D 15A levels were significantly (P < 0.0(1) lower in the animals that received
adenovirally-infected cell grafts than at 1 and 2 weeks, whereas in those that received
lentivirally infected cell grafts D 15A levels were not significantly different at 2 and 4
weeks. Downregulation in the animals that received retrovirally-infected cell grafts was
rapid, with significantly (P < 0.001) lower D15A levels (20-fold) at 2 and 4 weeks postgrafting.

29

Dose Dependency qj"Transgene Expression In Vivo

To compare levels of protein expression in response to different concentrations of
5

adenovirus and lentivirus, we tested a low I x 10 TU/IlI (Huber, Ehrengruber et al. 2000;
5

Jakobsson, Ericson et al. 2003) and a moderately high 5 x 10 TU/IlI (Byrnes, Rusby et al.
5

1995) dose. Expression ofD15A with both constructs was 3-fold higher in the 5 x 10
TU/IlI group at 1 week. Although not strictly I: I, gene expression was significantly (P <
0.00 I) dependent on the viral titer. There was no statistically significant difference in
D 15A levels between the adenovirus and lentivirus infected groups when the same viral

titers were used (Fig. 2.3).
Our initial observations with lentiviral-LacZ injections showed an area of necrosis
and tissue destruction (data not shown). We were, however, ablle to eliminate much of
that by removing serum from the media during viral preparation in later experiments.
These findings are in agreement with previous reports showing a focal necrosis
associated with the point of lentiviral injection that was always greater than PBS injection
(Zhao, Strappe et al. 2(03). We also saw a decrease in NeuN immunoreactivity in the rat
spinal cord after lentiviral injection. Baekelandt et al. (2003) have observed a similar
decrease in the rat brain and confirmed that this decrease was not associated with
neuronal death or apoptosis. These adverse effects are not due to the vector transduction
per se but seem to be a result of components of the culture system used in viral
preparation, which has been similarly observed in clinical trials for SCID and HIV
patients (Selvaggi, Walker et al. 1997; Tuschong, Soenen et al. 2(02). Several
purification methods were suggested to eliminate this immune response including sucrose
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gradient ultracentrifugation, although this is associated with a dlecrease in viral titers, and
the elimination of serum from culture system (Baekelandt, Eggermont et a!. 2003), which
in our hands successfully reduced the tissue damage initially observed. Virus prepared
under serum-free conditions was used for all data presented in this study.
Lentivirus produces a mild inflammatory response after in vivo delivery. We
evaluated the inflammatory response after the in vivo viral delivery for both lentivirus
+

and adenovirus, as well as after injection of PBS. Lentivirus produced very mild ED I
cellular infiltration that was confined to the injection site (Fig. 2.4A). Adenoviral
+

injections induced massive ED I cellular infiltration that was distributed over multiple
spinal segments (Fig. 2.4C) both rostral and caudal to the injection site, at I-week postinjection. Intraperitoneal injection of purified monoclonal antibodies against the rat CD4
and CD4S (OX-38 and OX-22) lymphocytic receptors reduced the inflammatory response
+

(Fig. 2.4B). The number of ED I cells at I week after lentivirus injection was not
significantly different from animals that received PBS or adenovirus injection combined
6

with monoclonal antibodies OX22/0X38 (Fig. 2.4F). When higher dose virus (1 x 10
+

+

TU//lI) was used, ED-I /OX42 cellular infiltration was also similar in the lentivirus and

adenovirus combined with mAb treated groups (Fig. 2.SK, L).

Lentivirus and Adenovirus Infect Mainly Astrocytes A.fier Low Titer Injection
Histologic evaluation of the viral tropism in the spinal cord after in vivo delivery
5

of low titer (I x 10 TV//ll) lentiviral and adenoviral + mAb OX22/0X38 injections
+

showed double-labeled cells that were mainly GFAP astrocytes (Fig. 4D,E). No APC
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+

+

+

oligodendrocytes (Fig. 2.4G, H) or NeuN neurons (Fig. 2.41, J) were infected. Few ED 1
+

and OX42 microglia were seen in the area of injection (Fig. 2.4L, M, 0, P). No CD4 Tcell lymphocytes (Fig. 2.4K, N) were seen at 1 week after lentiviral injection. The
rostrocaudal extension ofEGFP labeling was 3.0 6 O.S mm, indicating limited diffusion
of virus after low titer injection. Four weeks after low titer adenoviral + mAb
+

OX22/0X38 injection EGFP cells were still seen in the spinal cord (Fig. 2.4Q).

High Titer Viral injections
To evaluate viral tropism after high dose viral administration, we injected 1!i1
6

containing 1 x 10 TU (Blomer, Na1dini et al. 1997; Hermens and Verhaagen 1997) of
either 1entivirus or adenovirus + mAb OX22/0X38 into the thoracic spinal cord. One
week after viral injection, EGFP labeling was spread over the entire ventral segment of
the spinal cord (Fig. 2.SA, B). Cells resembling ependymal cells surrounding the central
canal were also infected (inset in Fig. 2.4A, B).

~IJI

+

tubulin neurons (Fig. 2.Se, D) in the

ventral hom of the gray matter of the thoracic spinal cord were infected with both viruses.
+

+

In addition, EGFP I NFH axons were observed both in the ventral white matter and in
the ventral roots (Fig. 2.SE, F). The majority of infected cells in both the white and gray
+

+

matter of the spinal cord were GFAP astrocytes (Fig. SG, H). No APC oligodendrocytes
+

(Fig. 2.SI, J) were seen infected after lentiviral or adenoviral injection. ED 1 cells
+

infiltrating the injection site were seen (data not shown) and were similar to OX-42 (Fig.
+

+

2.SK, L) cellular infiltrates. None of the EDl IOX-42 infiltrating macrophages/microglia
were infected with either virus. The extent ofEGFP labeling was 8.0 ±3.0 mm after high
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titer injection indicating substantial diffusion of viral particles.

Temporal Profile of Lentiviral-and Adenoviral-Mediated Transgene Expression Afier In
Vivo Delivery to the Spinal Cord
5

We chose the lower viral titer (1 x 10 TU/IlI) to study the temporal expression of
D I5A after viral-mediated delivery in vivo. Titer/volume matched vector stocks were
injected into the thoracic spinal cord and gene expression was evaluated I, 2, and 4
weeks later (Fig. 2.6). ELISA for D 15A showed that although all groups were
significantly higher (P < 0.001) than the basal levels of NT -3, there was no significant
difference between groups at I-week post-injection. Lentiviral transgene delivery showed
a stable pattern of gene expression. D 15A levels in the lentivirus group were not
significantly different at I, 2, and 4 weeks, with D 15A levels being significantly higher
than both adenovirus groups at 4 weeks. Adenoviral delivery of 0 15A showed significant
downregulation with expression levels gradually decreasing at 2 weeks (P < 0.001) and 4
weeks (P < 0.05). D15A levels in the adenovirus group were significantly (P < 0.001)
lower than the adenovirus + OX22/0X38 group at 2 weeks and both lentivirus (P <
0.0(1) and adenovirus + OX22/0X38 (P < 0.001) at 4 weeks.

Immune Suppression Eliminates Downregulation After Adenoviral Transgene Delivery In
Vivo.
In light of our histologic data indicating that the OX22/0X38 monoclonal
antibody treatment reduces the inflammatory response noted atl:er adenoviral trans-gene
delivery, we hypothesized that treating animals in the adenovirus group with

OX22/0X38 mAb 24 hr before and after viral injection would result in stabilization of
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gene expression and minimize the downregulation ofDI5A (NT3) expression. Our in
vivo results confirmed that the use of immuno-blockade successfully reduces
downregulation of D 15A after adenovirus injection. At 2 weeks post-injection, D15A
(NT-3) levels were significantly higher (P < 0.05) than adenovirus alone, but were not
different from lentivirus (Fig. 2.6). At 4 weeks post-infection, D 15A levels were
significantly lower (P < 0.001) than the lentivirus group, but they were significantly
higher (P < 0.00 I) than the adenovirus alone group.

Inducible D 15A Expression Afier Ex Vivo Delivery With Tet-on Vectors
Constitutive expression of trans genes may not always be desirable, as the ability
to tum a gene on or off at specific times may be therapeutically beneficial. To address the
feasibility of this approach, we used the tetracycline-inducible, Tet-on retroviral system.
Schwann, RN33B, and NIH3T3 cells were infected in vitro with the two virus Tetinducible system. After antibiotic selection for 1 week, induction of gene expression with
the addition of doxycycline to the culture media showed robust gene expression in vitro
with increasing concentrations of doxycycline. Although, D15A (NT-3) levels increased
about 50-fold over basal expression levels with 6 fIg/ ml of doxycycline and was
significantly (P < 0.05) higher than baseline expression, no significant difference was
5

found between 2, 4, and 6 fIg/ml doxycycline. Baseline expression was 40 pg/1 x 10
cells/m1l24hr, showing that the system is somewhat leaky with respect to its transregulation (Fig. 2.7 A). In the initial phase of this experiment, we noted a wide range of
variation of gene expression levels in vitro, with between 5-25··fold increase observed
after the doxycycline induction (data not shown). However, selecting stable clones using
G418 for up to 2 weeks resulted in clones that exhibited stable transgene integration and
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expreSSIOn.

5

For ex vivo delivery of DI5A, we injected I x 10

celll~d

RN33B cells into the

spinal cord. Animals were given doxycycline (1 mg/ml) in their drinking water for up
t02weeks. D15A (NT-3) expression in the spinal cord increased significantly, 7-fold at 1
week (Fig. 2.78). There was no statistically significant difference in DI5A expression
between 1 and 2 weeks in animals that received doxycycline for 2 weeks. In one group,
doxycycline administration was stopped after 1 week (light gray bars), a significant
reduction (P < 0.0 I, 2-fold) in 0 15A expression at 2 weeks was observed. At 2 weeks
post-grafting, 0 15A levels (black bars) were significantly higher than normal (P < 0.00 I,
5-fold), no-doxycycline (dark gray bars) (P < 0.001, 2-fold) and animals that received
doxycycline for only 1 week (P < 0.01, 1.5fold). Note that, at 1 and 2 weeks, levels of
DI5A in the absence of doxycycline are significantly higher at 1 week (P < 0.05, 3-fold)
and 2 weeks after the doxycycline induction (P < 0.01, 2.5-fold) than the control values,
again reflecting the inherent leakiness of this expression system.

DISCUSSION

Transfer of therapeutically beneficial genes to the CNS is an experimental
concept that potentially can be tailored and applied to a variety of CNS disorders. This
approach may be designed according to specific therapeutic requirements. In diseases
characterized by a chronic and progressive course (e.g., Parkinson's disease), a sustained
administration of the therapeutic molecule (Costantini, Bakowska et al. 2000; Johansen,
Rosenblad et al. 2002) may be appropriate, whereas for other disorders a transient
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delivery may be applied. The purpose of the current study was to evaluate various viral
delivery techniques, to better understand the temporal pattem of gene expression, as well
as the inflammatory response that follows viral injection, with specific attention to the
spinal cord as a unique eNS environment.
We have chosen to compare lentiviral and adenoviral vectors because oftheir
pantropic nature in the nervous system after in vivo delivery. Other viral vectors used
currently for gene therapy, HSV and AA V, are mainly neurotropic (Geller, Yu et al.
1997; Buning, Nicklin et al. 2003) in vivo.
We show that high titer injections of adenovirus and lentivirus into the eNS are
both pantropic transducing mostly neurons and astrocytes after parenchymal injection,
consistent with previous reports (Le Gal La Salle, Robert et a!. 1993; Huber, Ehrengruber
et al. 2000). Ependymal cells are also infected in our study after parenchymal injections
(Fig. 4A,B) and after intra-ventricular injection by others (Bajocchi, Feldman et a!.
1993). Oligodendrocytes have been only transduced in vitro (Ohashi, Watabe et a!. 1995).
In our hands, no oligodendrocytes were infected in vivo after viral administration. After
lentiviral injection in the mouse substantia nigra, 45% of cells were neurons and 17%
were astrocytes (Bensadoun, Deglon et al. 2000), whereas in the rat brain the majority of
transduced cells were neurons (Naldini, Blomer et al. 1996; 1996).

The use of a lentiviral vector pseudotype with VSV -G (Bums, Friedmann et al.
1993) gives this system an extremely broad host range in the eNS (Blomer, Nalldini et a!.
1997; Kordower, Bloch et a!. 1999) making it most suitable for delivery of therapeutic
molecules for different parts of the eNS where different populations of eNS neurons and

36

glia exist. Watson et a1. (Watson, Kobinger et a1. 2002) used pseudotype lentivirus with
Mokola, lymphocytic choriomeningitis virus (LCMV), and VSV-G and showed that
similar populations were infected by all three types both in vitro and in vivo, with
Mokola pseudotype-virus being most efficient when injected in mouse striatum and
hippocampus. In contrast, no transduction resulted from injection of Ebola-pseudotype
virus. Englund (2000) and Falk (2002) have also shown limited efficiency oflentiviral
vectors in mice. Although many studies support the notion that VSV -G-coated lentivirus
is neurotropic in the brain (Blomer, Naldini et a1. 1997; Kordower, Bloch et a1. 1999),
lakobsson et a1. (2003) provided evidence that VSV -G allows transduction of both glial
and neuronal cells and the promoter dictates in what cell type the trans gene will be
expressed. The present study detected no difference in the ability of lentivirus and
adenovirus to infect Schwann cells and other cell lines in vitro. This contrasts with others
who have shown adenovirus to be superior for infection of murine neural stem cells
(Falk, Holmstrom et a1. 2002). These discrepancies are likely due to murine-specific
differences that limit lentivirus nuclear entry and integration leading to decreased
transgene production (Johansson, Momma et a1. 1999; Englund, Ericson et a1. 2000; Falk,
Holmstrom et a1. 2002).
Lentiviral injection into the spinal cord resulted in stable transgene expression
with minimal inflammatory response and tissue damage making this system ideal for
+

situations that require long term delivery of therapeutic molecules to the CNS. r1gal (data
+

not shown) and EGFP cells were detected as far as 3-4 mm from the injection site for up
to 4 weeks post-injection (the longest time point evaluated). In previous studies, the
extent of ~gal staining ranged from 1 mm from the injection site after a 1f,ll injection of 3
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8
X

10 TU/ml (Bensadoun, Deglon et al. 2000) to several millimeters away from the

injection site. In all cases, long-term expression of the trans-gene was seen for periods
ranging from 60 days (Zhao, Strappe et a1. 2003) to 6 months post-injection (Blomer,
Naldini et a1. 1997), with retrograde transport of the virus after injection in the spinal
cord, to the substantia nigra and the nigrostriatal (Blomer, Naldini et al. 1997).

Not unexpectedly, protein levels after adenovirus-mediated transgene delivery
were dose-dependent, although not strictly 1: 1. Transgene expression also downregulated
5

after the administration oflow titers of adenovirus (1 x 10 TU/I.d). Others have used
6

9

moderate (5 x 10 TU/)ll) (Romero and Smith 1998) to high titers (1 x 10 TU/)ll) (Zhou
and Shine 2003) in an effort to achieve higher expression of trans gene. Although we have
only studied the temporal expression after low dose virus delivery, we would anticipate
the downregulation after higher doses to be comparable to that observed here, albeit with
a more intense inflammatory response. Previous studies have shown that at higher
concentrations, the majority ofCNS infected cells cease transgene expression within 2
weeks after administration or degenerate due to an immune inflammatory response
(Hermens and Verhaagen 1997; Peltekian, Parrish et al. 1997). This downregulation of
adenovirus driven expression has also been observed by others employing it in both ex
vivo (Blits, Dijkhuizen et al. 1999) and in vivo (Zhou and Shine 2003) approaches. Non-

integrating adenoviral vectors are almost certainly lost during cell replication, but
adenovirus expression can be persistent in grafted post-mitotic cells (Boer, van Esseveldt
et a1. 200 1).
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Monoclonal antibodies against CD4 and CD45 T lymphocyte receptors
successfully reduced transgene downregulation after adenoviral administration,
contributing to significantly higher D15A expression for up to 4 weeks post-infection.
This is in agreement with previous work by Romero and Smith (1998). Several other
strategies have been developed to avoid this downregulation and inflammation, including
the use of immune suppressors (cyclosporine and cyclophosphamide) (Dai, Schwarz et al.
1995), or monoclonal antibodies to CD4, CD40, and TCR (Guerette, Vilquin et a1. 1996;
Scaria, St George et a1. 1997; Zsengeller, Boivin et al. 1997). This strategy likely
eliminates only one cause for the downregulation after adenoviral gene delivery as later
downregulation may still occur due to a delayed immune response, or cell death.

Although promoter silencing can be a cause for downregulation of trans gene
production after viral gene delivery, it is not in our opinion the reason for the noted
differences in transgene expression patterns between lentivirus and adenovirus noted in
the present study, as both lentiviral and adenoviral vectors used CMV promoter to drive
D 15A expression. Also down-regulation after in vivo adenoviral delivery has been
reversed, at least in part, by modifying the animal's immune response using monoclonal
antibodies against CD4 and CD45 T lymphocyte receptors. These data are consistent with
an immune-mediated removal of infected cells in the presence of activated T cells.
One significant finding of this study shows that although EGFP levels were
histologically detectable weeks after adenoviral injection, the downregulation of D l5A
assessed by ELISA was greater than what would have been predicted by the qualitative
levels of EGFP. These data indicate that using marker proteins as the sole measure to

39

assess the temporal expression after viral injection is problematic. Most studies have
relied on histochemical or immunohistologic methods to analyze the duration of
transgene expression in neural cells (Bennett, Wilson et al. 1994; Akli, Guidotti et al.
1996) leading to difficulties of interpretations and variable conclusions. For example,
although ~gal has been seen up to 2 months after adenoviral injection (Byrnes, Rusby et
al. 1995), others showed rapid downregulation after in vivo and ex vivo studies using
both

~gal

histochemistry (Blits, Dijkhuizen et al. 1999) and NT -3 ELISA (Zhou and

Shine 2003). Using RT-PCR to detect GDNF mRNA, Baumgar1ner and Shine (1998)
showed adenoviral-driven gene expression in the spinal cord at 3 weeks, but no
detectable levels at 6 weeks after adenoviral injection. Collectively, these results indicate
that direct assessment of the relevant protein should be employed to measure transgene
expressIOn.
The ex vivo gene transfer results using the LZRS retrovirus with a constitutive 5
LTR promoter in Schwann cells showed rapid downregulation of gene expression by 2
weeks post-grafting. These findings are in agreement with previous reports, which have
shown variable transgene downregulation independent of either the promoter or cell type
used (Liu, Himes et al. 1999; Johansen, Rosenblad et al. 2002). This downregulation and
variability is believed to be due to the random integration into the host genome, and the
issue has been raised about possible complications related to permanently modifying the
host genotype, triggering insertional mutagenesis and the activation of proto-oncogene in
host cells (Kohn, Sadelain et al. 2003; Noguchi 2003). This would likely be a very rare
event, however, and the rapid downregulation of trans-gene expression could prove
useful when only transient spinal cord expression is desired.
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We show robust, doxycycline-dependent induction of gene expression ex vivo
with the tetracycline-regulated promoter. Basal expression levels were detectable and
were significantly higher than control animals, however, indicating incomplete
transcriptional regulation in the absence of doxycycline, highlighting one problem related
to the use of this system. Blesch et al. (2001) have shown efficient gene expression for a
period of 3 months in vivo using a tet-ofT system, whereas others reported varying basal
expression using tet-on system in vitro (Paulus, Baur et al. 2000) and marked
downregulation immediately after transplantation into the rat striatum (Johansen,
Rosenblad et al. 2(02). Our findings are in line with the latter study, in that we report
significant basal expression both in vitro and ex vivo. The basal expression level
observed in vitro as well as in vivo in the present study may be explained by multiple
factors including, but not limited to, enhancer elements in the promoter, low affinity
binding of the activator to the tetracycline responsive element ('IRE) in the absence of
doxycycline, or basal activity of the promoter (Johansen, Rosenblad et al. 2002).
In summary, the results of the present study indicate that: 1) lentiviral-mediated
gene delivery is best suited for situations when long-term delivery of a trans-gene is
needed, whereas ex vivo retroviral delivery system is more appropriate for transient
delivery of therapeutic molecules, with adenoviral-driven expression intermediate; 2) the
use of transgene-specific assays to determine the protein level after delivery are more
reliable and biologically relevant than the use of marker proteins as indicators of
transgene levels; and 3) protein levels are dependent on viral titer, as greater
concentrations of the therapeutic molecules can be obtained by increasing viral dose. The
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caveat to this later point is that as viral loads increase, so does the extent of the
inflammatory response.
Taken together, these results provide further support for the use of viral vectors
for gene transfer of therapeutic molecules aimed at enhancing regeneration after SCI.
Moreover, results indicate that multiple viral delivery approaches may be used singly or
in combination to achieve a targeted temporal, as well as spatial, delivery of transgene to
the injured CNS.
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Table 2.1: D15A (NT-3) expression (pg/ 24 hours/ml) in conditioned media ofSchwann
cells, NIH3T3 and RN33B cells following viral infection in vitro.

Schwann
Cells
Fold
induction
NIH 3T3

No virus

Lentivirus

Adenovirus

41±10

3108±641

2742±568

***

***

75
506 I±704

49±12

LZRS
retrovirus
1578±288

MSCV
retrovirus
2278±541

66

38

55

8587±630

4570±784

2612±484

93

53

*
Fold
Induction
RN33B

103
244±110
#

Fold
induction

15273±1529
#,

62

***

175
10040±2378

7346±852

8590±731

#

#

#

41

30
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In Schwann cells, Dl5A (NT-3) levels in the lentiviral and adenoviral-infected
cells were not different from those in the MSCV retroviral-infected group but were
significantly higher than no virus and LZRS retrovirus (p<.OOl). In NIH 3T3 cells,
D15A levels in adenoviral-infected cells was significantly higher (p<.OOI) than all other
groups. MSCV infected cells, D 15A levels were significantly (p<.OO I) lower than all
other viral infected groups. In RN33B cells, D 15A levels were significantly higher (#
p<.OO 1) than other cell types in all groups tested. D 15A levels in the Lentiviral infected
RN33B cells were significantly higher (p<.OOl) than all other viruses. All cells were
seeded at lx10 5 ce11lwel1. Data are expressed as mean pg D15PJ24hours/ml ± SD (n = 6).
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Figure Legends

Figure 2.1. Schwann cells were infected in vitro with either lentivirus (A), adenovirus
(B), or retrovirus (C) (MOl =20). Cells were stained for EGFP and counterstained with
Hoechst 33342. TrkC expressing PC12 cells (arrow heads in D) were used to determine
the bioactivity of DIS A. Recombinant human (rh) NT-3 was added (100 pg/ml-1 ng/ml)
to the media ofPC12 cells for 3-4 days" neurite outgrowth from PC12 cells (arrow heads
in E) was compared to that of conditioned media of infected NIH3 T3 cells added at a
concentration range of 10-100%, bioactive D lSA in media was identified by examining
neurite outgrowth (arrowheads in F) from PC12 cells. Conditioned media at a
concentration of 7S-1 00% were similar to an NT -3 concentration of SOO pg/ml-1 ng/ml.
Control PC12 cells (D) maintained on DMEM did not show any neurite outgrowth. There
was no difference between conditioned media collected from NIH3T3 cells infected with
lentivirus, adenovirus, or retrovirus. Scale bar = 40 11m.

Figure 2.2. Temporal expression of DIS A in the spinal cord after ex vivo gene delivery
using lentivirus, adenovirus, EGFP, and retrovirus. Schwann cells were infected with
similar MOl (20) and 48 hr later 1 x 105 cells were transplanted into the spinal cord.
There was no significant difference between normal spinal cord and EGFP-infected
groups at any of the three time points. DlSA expression was significantly higher (P <
0.001) in the lentiviral-infected group than normal, EGFP, and retrovirus infected groups
at 1 and 2 weeks. No significant difference was found between lentiviral and adenoviral
infected groups at 1- and 2-weeks post-transplantation. At 4 weeks, D lSA expression was
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significantly higher (P < 0.001) in the lentiviral-infected group than all other groups. In
the adenoviral-infected group, D15A levels were significantly lower (P < 0.001) at 4
weeks. Downregulation ofD15A in the retroviral-infected group was rapid with
significantly lower (P < 0.001) 0 15A le:vels at 2 and 4 weeks compared to that of 1 week.
Although the lentiviral-infected group showed some downregulation with D 15A levels
significantly lower (P < 0.01) at 2 weeks, 0 15A levels plateau and were not significantly
different at 2 and 4 weeks. Data shown are the mean ± SD (n =4).

Figure 2.3. D 15A protein expression is dependent on viral titer. One microliter of 1 x
5

10 TU/Ill or 5 x 105 TV/Ill of virus was injected into the spinal cord. One week after
injection, expression ofOI5A was significantly (P < 0.001) higher than normal in all
groups tested. D15A levels were significantly higher after high titer adenoviral (5 x 105
5

TU/IlI, n = 3; P =0.001) and lentiviral injections (5 x 10 TU/IlI, n = 3/group; P < 0.001)
than after the low titer injections (1 x 105 TV/Ill, n =6/group). DI5A expression was not
significantly different between titer matched adenoviral and lentiviral injected groups.
Data shown are mean ± SO.

Figure 2.4. Inflammatory response and cell-specific infection by low titer lentiviral and
adenoviral vectors in the spinal cord. Photomicrographs taken within 2 mm from the
injection site show representative sections after; lentivirus (A,D,G,I,L,N,O), adenovirus +
mAb OX22/0X38 (B,E,H,J,K,M,P,Q) and adenovirus (C) injections. In both lentivirus
(A) and antibody-treated adenovirus groups (B) ED 1+ cells were limited to the area
surrounding the injection site (arrows), whereas in the non-antibody treated adenovirus
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group (C) ED 1+ cells were widespread over the entire gray and white matter of the spinal
cord. EDl+ cells were counted (F) in five sections 2 mm from the injection site from
each animal. Cells were counted using ]mageproPlus ® software in an entire 20x field.
The numbers of ED I + cells in the adenovirus group were significantly higher (P < 0.001)
than all other groups. There was no significant difference among PBS, lentivirus, and
adenovirus + mAb groups. Data shown are the mean ± SD, (n == 7/group). To identify
cellular phenotypes infected with low titer (1 x 105 TU//ll) lentivirus and adenovirus,
sections were double-labeled for EGFP (green) and the cell-specific markers; neurons
(NeuN), oligodendrocytes (APC), astrocytes (GF AP), microglialmacrophages ED1/0X42, and T lymphocytes (CD4). Confocal microscopy showed that astrocytes
(arrows) were infected with both viruses (D,E). In contrast, APC+ oligodendrocytes
(G,H) and NeuN+ neurons (I,J) (arrows) were not infected after both viral injections. A
decrease in NeuN immunoreactivity was also seen after lentiviral injection but not after
adenoviral injection with immune suppression. CD4+ T cells were not seen 1 week after
low titer adenoviral injection with the OX22/0X38 immunosuppression (K) or lentiviral
injection (N).
EDl+ macrophages (L,M) and OX42+ reactive microglia (O,P; arrows) were not
infected after either viral injection. EGFP labeling was detected at 4 weeks after
adenoviral injection with OX22/0X38 immunosuppression (anrows in Q). Data are
representative of five animals per group. Scale bar = 200 /lm (in A,B); 20 /lm (in D-P),
and 80 /lm (C,Q).
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Figure 2.5. Identification of cell types infected with high titer lentivirus and adenovirus.
EGFP labeling was found in both the gray and white matter of the spinal cord after
lentiviral (A,C,E,G,I,K) and adenoviral (B,D,F,H,J,L) injections. Ependymal cells
surrounding the central canal were infected by both types of viruses that could be clearly
seen at high magnifications (arrows in A,B; insets in A and B are from adjacent sections).
EGFP labeling was localized in

~III

tubulin+ neurons (C,D;

an~ows),

NFH+ axons in the

ventral white matter (E,F; arrows) and the ventral rootlets (E,F; triangular arrow heads)
associated with motor neurons as well as GFAP+ astrocytes (G,H; arrows). In contrast,
neither oligodendrocytes (I, J; arrows) nor reactive microglia/macrophages (K,L; arrows)
were labeled with EGFP. Scale bar =200 11m (A,B); 40 11m (C,F and insets in A,B); 20
Ilm (in G,H,K,L); 13 11m (I,J). cc, central canal; VH, ventral hom; VR, ventral root. Data
are representative ofn =5 animals/group.

Figure 2.6. Temporal expression ofD15A in the spinal cord after in vivo gene delivery.
Lentiviral delivery resulted in robust and stable gene expression for up to 4 weeks postinjection. At 4 weeks post-injection, the: D15A levels were significantly higher than both
adenoviral infected groups (P < 0.001). In contrast, adenoviral infection showed
significant downregulation ofD15A at 2 (P < 0.001) and 4 weeks (P < 0.05) postinfection. Treatment of animals with mAb OX-22/0X-38 successfully reduced the
downregulation of adenoviral-delivered D 15A expression compared to the nonOX22/0X38 treated groups that was significantly lower (P < 0.001) than lentivirus and
adenovirus + mAb groups at 4 weeks. Data represent the mean ± SD (n =5/ experimental
group).
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Figure 2.7. Induction of DIS A expression using doxycycline (Dox) in vitro (A) and in
vivo (B). A: NIH/3T3 cells were transduced in vitro using the two virus (pRev-Tre DISA
and pRev-Tre Tet-on) tetracycline inducible Tet-on system. After antibiotic selection for
1 week in vitro, increasing Dox concentrations were added to the culture media. No
significant difference was found betwec:n 2, 4, and 6
levels at 6

~g/ml

~g/

ml Dox concentrations. D lSA

Dox were significantly higher than baseline expression (P < O.OS). Data

shown are the mean 6 SD (n

=

S/experimental group). B: 1 3 lOS DISA infected RN33B

cells were injected into the spinal cord. After the addition of 1 mg/ml Dox to the animal's
drinking water, D1SA levels at 1 week were significantly higher than both normal (open
bars, P < 0.001) and no-Dox (dark gray bars, P < 0.001) groups. In one group of animals,
Dox administration was stopped after 1 week, which resulted in a significant drop in
D 15A levels at 2 weeks (light gray bars, P < 0.001). At 2 weeks, D ISA levels in the
group that received Dox for 2 weeks were significantly higher than normal (black bars, P
< 0.0(1), no-Dox (P < 0.(01) and animals that received Dox for only 1 week (P < 0.01).
Basal expression levels were detectable and were significantly higher (P < 0.05 at 1 week
and P < 0.01 at 2 weeks) than in control animals indicating incomplete transcriptional
regulation in the absence ofDox. Data shown are the mean ± SD (n =4).
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Lentivirus

Adenovirus

52

Figure 2.6

*
***

700
600

o Normal
• Adenovirus
DAdeno+Ab
o Lentivirus

***
,------,
***

C 500
Ow
......

2

0..
01

400

........
01

300

E

.3-

«

Lf)

.0

***

200
100

a

~
Normal cord

2weeks

1week

53

4weeks

Figure 2.7

A

...c

4

.q-

N
.........

E3

.........
Vl

OJ
U

o 2

.-

.........
0)

c

«1
lJ")

.0

2

0

4

6

ug/ml Doxycycline

B

• Dox 2wk

D

Dox 1wk

D

No Dox

***
***
350

***

c

'(j)

.....
o>--

D-

O)

E

~

~'?;

«

lJ")

o
50

Normal cord

1Wk post -graft

54

2Wk post-graft

CHAPTER 3
AXONAL REGENERATION INTO SCHWANN CELL-SEEDED PAN/PVC
GUIDANCE CHANNELS FOLLOWING A MID-THORACIC SPINAL CORD
HEMISECTION: A COMPARISON BETWEEN 3 TYPES OF CHANNEL
GEOMETRY

INTRODUCTION
Spinal cord injury (SCI) produces damage of ascending and descending axons in
the spinal cord, leading to long lasting functional loss with glial scarring and cavity
formation that form barriers to regenerating axons. To overcome these barriers, different
bridging modalities and tissue engineering strategies (reviewed in (Geller and Fawcett
2002; Zhang, Yan et al. 2005)) offer promising results for regeneration through and
beyond the injury site. Schwann cells (SCs) were successfully used to promote axonal
regeneration and myelination in spinal cord injury models using either biodegradable
tubular scaffolds made of poly lactic acid (Oudega, Gautier et al. 2001), polylactide-coglycolide (PLGA) (1999; Hadlock, Sundback et al. 2000) or non-biodegradable
polyacrylonitrile and polyvinylchloride copolymer (PAN/PVC) channels (Xu, Guenard et
al. 1995; 1995; 1999). Studies of the effect of filaments with a diameter ranging from 5IOOllm, used alone or inside a sleeve, have demonstrated axonal and glial alignment
parallel to the long axis of filaments both in vitro and in vivo (Khan, Dauzvardis et al.
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1991; Terada, Bjursten et al. 1997; Steuer, Fadale et al. 1999; Rangappa, Romero et al.
2000).
Previously, we demonstrated successful axonal regeneration into a large (outer
diameter, OD, 3mm) or small (OD, 1.25 mm) diameter, smooth inner surfaced PAN/PVC
guidance channels seeded with SCs after either a total transection or hemisection,
respectively, of the spinal cord (Xu, Guenard et al. 1995; 1995; 1999; Bamber, Li et al.
2001; Iannotti, Li et al. 2003). In this study we compared three types of channels that
either having two different inner wall surface topography (smooth or grooved inner
surface) or channels filled with filaments measuring 20/lm in diameter.

MATERIAL AND METHODS

Forty four adult female Sprague-Dawley (SD) rats (150-175 g) were divided into
three groups. Group I (n= 15) received transplantation of a channel with smooth inner
wall, group 2 (n= 20) received a channel with grooved inner wall, and group 3 (n= 9)
received a channel that filled with densely packed filaments of 20 /lm in diameter. In all
groups, SCs were seeded into guidance channels at a density of 120x106/ml prior to
transplantation, as described previously (Xu, Guenard et al. 1995).

Schwann cell preparation

The procedures for harvesting and preparation of purified populations of rat SCs
were described in previous publications (Xu, Guenard et al. 1995; 1997). Briefly, SCs
were harvested from the sciatic nerve of adult SD rats (Harlan, Indianapolis, IN) under
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aseptic conditions, purified and expanded in culture. The purity of the SCs was
ascertained by previously described methods (Xu, Guenard et al. 1995; 1997). When the
purified SCs reached confluence, they were collected for either in vitro spinal cord
explant culture or seeding into mini-guidance channels.

Surgery & Transplantation

Under appropriate anesthesia with pentobarbital (40 mg/kg IP), the thoracic spinal
cord was exposed with a laminectomy at T8 vertebra and the dura incised longitudinally.
A right side hemi-section was performed using iridectomy scissors and a 3 mm segment
of the spinal cord removed. A 3 x 1.25 mm SC-seeded mini-channel was placed in the
hemisection gap. The dura was closed with 10-0 nylon suture and the wound was closed
in layers. The animals were allowed to recover from anesthesia before being returned to
their cages. Post-operative care followed previously reported protocols (Xu, Zhang et al.
1999), and all animal handling, surgical procedures, and post-operative care were
provided in strict accordance with the Guide for the Care and Use of Laboratory Animals
(National Research Council, 1996) and the Guidelines and Policies for Rodent Survival
Surgery provided by the Animal Care Committees of University of Louisville.

Perfusion, histology, and immunohistochemistry

Six weeks after surgery, rats were anesthetized deeply with pentobarbital and
transcardially perfused with 200 ml 0.1 M phosphate buffer (PB) (pH 7.4), followed by
250-300 ml of ice-cold 4% para-formaldehyde in 0.1 M phosphate buffer (pH 7.4). A
2.5 cm segment of the spinal cord spanning the transplantation site was removed and
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post-fixed for 2 hours at 4°C, then transferred to 30% sucrose in O.IM PB for
cryoprotection until sectioned. The middle 1 mm segment of the channel and adjacent
cord was cut, fixed in 1% Osmium oxide in O.IM cacodylate buffer, dehydrated, and
epoxy resin embedded. One micron (l/Jm) semi-thin sections were cut and stained with
1% toluidine blue. The proximal and distal channel-cord segments were sectioned
longitudinally on a Leica cryostat at 20-25 /Jm and mounted on microscope slides.
Sections were rinsed in phosphate buffered saline (PBS), blocked and permeabilized in
PBS containing 10% normal donkey serum (NDS) and 0.3%) Triton X-IOO for 1 hr at
room temperature, and incubated in primary antibody overnight at 40C, with 5% NOS,
and 0.25% Triton X-I 00 in PBS. Polyc1onal rabbit anti-glial fibrillary acidic protein
antibody (anti-GF AP; 1: 100, Chemic on, Temecula, CA), was used to identify astrocytes.
Twenty four hours later, sections were rinsed in PBS and incubated in either fluoresceinconjugated or rhodamine-conjugated Fab' fragment secondary antibodies from donkey
(1: 100; Jackson Laboratories, Baltimore, MD). Slides were washed in PBS, mounted,

and examined using fluorescent microscope and photographed. Figures were assembled
using Adobe Illustrator® software.

Data analysis
Myelinated axons, blood ve:ssels and tissue cable mid-section area were
determined on l!lm semi-thin, toludine blue-stained sections using a stereology
workstation (Stereolnvestigator; MicroBrightField, Williston, VT, USA). The examiners
were blinded for the groups of animals. Four to six sections per animal were counted and
the mean was calculated for each animal. The area of tissue cable was delineated using a
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4x objective lens, and then divided in counting frames of 40 by 40)lm using the Optical
Fractionator probe. Counting was performed using an oil-immersion objective with a
high numerical aperture (l00 x, oil, NA=1.00). Section thickness was measured for every
section counted per animal (~1 )lm). Total numbers of myelinated axons and blood
vessels in the tissue cable were generated using the stereo-investigator® software, by
multiplying the numbers of counted axons or blood vessels with the sampling probability
(for technical details see (Schmitz and Hof 2000). One way ANOV A was used to
compare control values with experimental groups followed by Tukey's post-hoc
comparison test. A p value of <0.05 was considered as statistically significant.

RESULTS
To study the effect of the internal surface of the channel on axonal regeneration
we used a smooth inner wall channel (Fig. 3.1A, D, G, J) and a grooved inner wall
channel (Fig. 3.1 B, E, H, K); the channels filled with filaments (Fig. 3.1 C, F, I, L) were
used in a second comparison based on our hypothesis that fiilaments would form an extra
scaffold to enhance axonal regeneration.
Using unbiased stereological counting of myelinated axons in the mid-section of
the tissue cable (Fig. 3.1M), the group with grooved inner wall had 730.66±252.76
myelinated axons. This was significantly higher (p<O.O I) than that of the smooth inner
wall group (539.4±287.63), indicating an enhancement of axonal regeneration when
grooved inner wall topography was provided. In contrast, channels filled with filaments
had a significantly lower (p<O.001) number of myelinated axons (l63.54±76.04) than
both grooved and smooth inner wall channel groups (Fig 3.1M).
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The cross-sectional area of the regenerative tissue cable at the graft mid-point
inside the channel was significantly higher in the filaments channel group (590865.3 ±

143344.2 11m2) when compared with the other two groups. This is due to the presence of
filaments in the tissue cable. The area of the tissue cable in the grooved channel
(216942.2± 83503.6 11m2) group was significantly higher (p<O.OO I) than that of the
smooth channel group (136435 ± 90009.2 11m2) (Fig 3.1N).

Stereological study of the number of blood vessels in the mid-section of the tissue
cable showed significantly lower number (16.96±11.77; p<O.OOI) of blood vessels in the
smooth inner wall channel group when compared with either the grooved channels group
(42.15±22.56) or filament-filled channel group (34.91±23.83) (Fig. 3.10). There was no
statistically significant difference in the number of blood vessels between the grooved
channels and filament-filled channels.
Immuno-histochemical study of the rostral and caudal graft host interface showed
successful apposition of the channel and the spinal tissue at both ends of the graft with
very limited cavity D)rmation.

DISCUSSION
Tissue engineering has a great potential to replace or restore the anatomical
structure and function of the injured spinal cord tissue. Biomaterials are combined with
cells in a three dimensional structure to support axonal growth and myelination across the
lesion gap. Previous work in our laboratory have shown successful regeneration and
myelination ofaxons in a PAN/PVC channel seeded with SCs with myelinated axon
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numbers ranging from 734 ±139 tOi lO04±126 when SCs were used alone or 935 ±323 to
1523 ±292 when Schwann cells were combined with neurotrophins (Xu, Guenard et al.
1995; 1999; Bamber, Li et al. 2001). In this study we show similar success in axonal
regeneration and myelination in the twOl non··filament groups, i.e. grooved
(730.66±252.76) and smooth (539.4±287.63) inner wall groups.
A significant finding of this study is that deep grooving of the inner surface of a
P AN/PVC channel enhances myelinated axonal numbers within grafts of SC-seeded
tissue cable. Although the exact mechanism by which longitudinal grooving affect axonal
regeneration remains unclear, one possibility is that grooves on the inner surface of the
channel provide greater contact interface between the spinal cord tissue and the channel
at the graft-host interface. During tissue healing after injury, the growth of regenerative
tissue is influenced by the topographical features created by cells, matrix molecules,
surfaces of biomaterials, a phenomenon which has been historically called contact
guidance (Weiss 1945). It has also been noted recently that mouse sympathetic axons
align to nano-imprinted patterns in vitro (Johansson, Carlberg et al. 2006) and
hippocampal neurons extend their axons on a micro-scale chemical pattern made of polyL-Iysine-laminin in vivo (Kam, Shain et al. 2001). These results indicate that the surface
topography has a significant role in axonal guidance and regeneration.
Aebischer et al (1990) examined the effect of surface microgeometry of the inner
wall of a guidance channel on myelination and morphology of regenerating peripheral
nerves. Smooth inner wall channels induced discrete nerve cables, while grooved
channels induced th(: formation of scattered nerve fascicles in an unorganized fibrin
matrix. Other factors may also contribute to axonal regeneration inside guidance channels
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including the molecular weight cutoff of the channel wall, and piezoelectric properties of
the guidance channels as previous studies show that electrically charged channels induce
more myelinated axons compared to uncharged ones (Fujiki, Kobayashi et a1. 2003;
Mangold, Keller et al. 2005).
In this study we tested whether a filament-filled channel, seeded with SCs,
promote the growth and myelination of regenerated axons following a thoracic spinal
cord hemisection. The number of myelinated axons in this kind of channel was
significantly lower than the other non-filament channels, indicating that at least at the
present density filaments do not enhance axonal regeneration. In fact they may have
physically impeded axonal growth into the graft because they occupied a significant area
of the potential space for the axons to regenerate. These filaments may need to be
modified either with coating with a regeneration enhancing extra-cellular matrix substrate
and/or using them at a lower density. In previous studies, Rangappa et al (2000) observed
higher neurite outgrowth rate on laminin pre··coated filament bundles compared to the
poly-L-lysine coated and uncoated controls. Wen et al (2006) compared different
diameters of filaments in vitro and showed enhanced Schwann cell migration on
filaments coated with laminin and successful alignment and robust outgrowth of neurites
on filament bundles in vitro with filament diameter in the range of 5 and 30 ).lm that was
enhanced with laminin and fibronectin coating of filaments. These observations indicate
the promise of using engineered filaments, combined with appropriate coating materials,
to enhance the growth and directionality of regenerated axons for better repair of the
injured spinal cord.
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Figure legend

Figure 3.1. Comparison between three types of channels. Photomicrograph showing
cross section of the non-grooved (a), grooved (b) and filament filled channel (c). Cross
section of a single filament is shown in higher magnification (inset in c). D-F show
higher magnification photomicrographs of the channel wall. Effective regeneration and
myelination ofaxons was observed with variable results in all channels used, G-L show
photomicrographs (G-I low power, J-L high power) from semi-thin toluidine blue stained
sections from the mid-segment of the tissue cable showing blood vessels (BV) and
filaments (F).
The number of myelinated axons was significantly lower in the filament group
compared to the other two groups, while myelinated axons were significantly higher in
the grooved channel group compared to the smooth channel group (m). The mid-section
cable area was significantly higher in the filament group compared to the other groups.
(Scale bars 200
p<O.OI,

~m

in A-C, 40

~m

D-F, 200

~m

*** p<O.OOI
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Figure 3.1 Comparison between three types of channels
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CHPATER4

AXONAL REGENERATION INTO GUIDANCE CHANNELS SEEDED WITH
NEUROTROPHIN-SECRETING SCHWANN CELLS FOLLOWING A MIDTHORACIC SPINAL CORD HEMISECTION: EFFECTS OF ALTERED
TEMPORAL EXPRESSION.

INTRODUCTION
SCs are an essential component to the injured CNS axons regeneration success
encountered in the early transplantation experiments using peripheral nerves (Blakemore
1977; Kao, Chang et al. 1977; Richardson, McGuinness et al. 1980; David and Aguayo
1985) as possible solution to the inhibitory nature of the injured spinal cord environment
following spinal cord injury (SCI). SCs naturally exhibit robust interaction with axons as
they proliferate and migrate along axons and eventually myelinate individual axons
(Oudega and Xu 2006). SCs also express the neurotrophin receptors tyrosine kinase
receptor TrkC and the low affinity neurotrophin receptor p75

NTR

(Chan, Cosgaya et al.

2001; Cosgaya, Chan et al. 2002). Brain derived neurotrophic factor (BDNF) enhances
SC myelination by interacting with p75 NTR . Neurotrophin-3 (NT -3) stimulates SC
migration (Maniwa, Iwata et al. 20103; Yamauchi, Chan et al. 2003), SCs populate areas
in the spinal cord following injury and remyelinate axons with peripheral type myelin
both in rats (Bresnahan 1978; Bunge 1983; Blakemore and Crang 1985; Titsworth,
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Onifer et al. 2007) and humans (Bunge 1994). Previously, Bamber et a1. (2001) showed
that BDNF and/or NT3 infusion into the spinal cord parenchyma enhanced axonal
regeneration and myelination only in SC groups compared to Matrigel only groups.
BDNF and NT3 infusion into guidance channels seeded with SCs enhanced axonal
regeneration from the stump of the transected adult rat spinal cord and myelination, with
predominantly serotonergic fibers invading the graft (Xu, Guenard et a1. 1995).
The combination of tissue engineering and SC transplantation offer a promising
approach to enhance axonal regeneration and functional recovery following SCI. In
Chapter 3, we compared three types of guidance channels made of polyacrylonitrile and
polyvinylchloride (PAN/PVC) co-polymers with smooth or grooved inner walls or filled
with filaments combined with SC grafts. We showed greater axonal growth and
myelination into the channels with grooved inner walls than channels with smooth inner
walls. The addition of filaments inside the channels did not enhance axonal
regeneration.
Menei and colleagues (Menei, Montero-Menei et a1. 1998) compared normal SCs
with SCs genetically modified to secrete human BDNF, grafted in the transection site as
well as a trail 5 mm long in the cord distal to a transection site. Schwann cells-BDNF
improved the regenerative response across a transection site in the thoracic cord.
Our previous work showedl that the expression of a transgene can be controlled
by utilizing the intrinsic characteristics of the viral delivery system (Abdellatif, Pelt et a1.
2006). For example, transgene expression following retroviral-mediated delivery downregulates reaching near baseline levels in approximately 2 weeks, whereas adenoviralmediated delivery peaked at 2 weeks dropping to 50% expression levels at 4 weeks. On
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the other hand, lentiviral-mediated delivery leads to longer lasting transgene expression.
To test whether different temporal expression levels ofneurotrophins from SC infected
with retroviral, adenoviral, or lentiviral vectors affect axonal regeneration and
myelination, we transplanted infected SC-seeded mini-channels into a thoracic SCI. We
also reported successful in vitro infection of SCs with adenovirus, retrovirus and
lentivirus carrying the cDNA for D 15A (Abdellatif, Pelt et a1. 2006), a bi-functional
neurotrophin molecule with BDNF and NT3 functions (Urfer, Tsoulfas et a1. 1994). We
hypothesize that the combination of SC transplantation and a defined time period of viralmediated transgene delivery will optimally enhance axonal regeneration and myelination.

MAT]~RIAL

AND METHODS

Cell culture.

SCs were isolated as described previously (Morrissey, Kleitman et al. 1991; Xu,
Zhang et a1. 1999). Briefly, sciatic nerves were dissected from pentobarbital
anaesthetized adult SD rats. Following removal of the epineurium and connective tissue,
nerves were cut into 1 mm explants and placed in 35 mm Coming tissue culture dishes
(Baxter, Stone Mountain, GA) containing Dulbecco's Modified Eagle's Medium
(DMEM; Gibco Lab., Grand Island, NY) supplemented with 10% FBS. Explants were
transferred to new culture dishes every 7 days with fresh medium. Five weeks later,
explants were incubated overnight in 1.25 Ulml dispase (Boehringer Mannheim
Biochemicals, Indianapolis, IN), 0 . 05% collagenase (Worthington Biochemicals Corp.,
Freehold, NJ), and 15% FBS in DMEM at 37°C in 5% CO 2 . The next day, explants were
dissociated and cells were plated onto poly-L-lysine-coated 100 mm dishes in
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DMEMIlO% FBS, containing 20 mg/ml pituitary extract (BTl, Stoughton, MA) and 2
mM forskolin (Sigma, St Louis, MO).

Viral vectors.
Adenoviral (Ad5-D15A), lentiviral (pLenti6-D15A), and retroviral (LZRS-D15A)
vectors, respectively, encoding DI5A, as well as control (LZRS expressing EGFP)
vectors were constructed, titered, concentrated, and used exactly as previously described
(Abdellatif, Pelt et all. 2006).

Animal groups.
Forty three adult female Sprague-Dawley (SD, Harlan, Indianapolis, IN) rats
were divided into experimental groups as shown in Table 4.1. Rats were housed 2-3 per
cage with free access to food and water under 12-hr lightdark cycle according to the
guidelines of the Institutional Animal Care and Use Committee (IACUC) at the
University of Louisville. Animals were anesthetized with pentobarbital (40 mg/kg IP).
All animals injected with live virus were isolated in a biohazard animal suite for 7 days
post injection and after 7 days were housed in common housing suites according to the
University of Louisville IACUC housing regulations. Animals received a right thoracic
hemisection and transplantation of a grooved inner wall channel seeded with LZRSD15A, pLenti6-D15A, or LZRS-EGFP SCs.

Hargreaves testing.

Two weeks prior to sacrifice, each rat was gently grasped by an observer blinded
to experimental groups and placed on the warmed (32°C) glass platform (36 cm x 95 em)
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(Model 400 heated base, lITC Life Sciences, Woodland Hills, CA) of a planter test
analgesia meter (Series 8, Model 390G, lITC Life Sciences, Woodland Hills, CA). The
testing head of the apparatus was placed 6 cm below the glass platform and a heated light
(42°C) focused on the glass surface: was applied to the plantar surface of both hind paws.
The time to withdrawal of each hind paw was recorded by another blinded observer. The
analgesia meter was set to a maximum exposure time of 20 seconds after which time the
light was automatically turned off. Each rat was tested 4-S times with a minimum of S
minutes between each test. The time to withdraw the injured side was compared with
that of the un-injured side. Uninjured sham and naive animals were included in the
analysis and statistical analyses performed as described below.

Grid walk test.

Once daily for a minimum of three trials per animal on three different days, each
rat was gently removed from its cage by its tail and placed in the middle of 1m x 1m wire
grid, with grid holes 3.S cm x 3.S cm (Onifer, Zhang et al. 200S). Two observers blinded
to the experimental groups, were positioned on opposite sides of the grid and counted the
left and right hind limb footfalls during 3 minutes of spontaneous locomotion. A footfall
was counted when the entire hind paw extended through a grid hole. The average
numbers of footfalls of the right side (injured for experimental groups) were compared to
the left side.

Histology.
Rats were anesthetized with pentobarbital and transcardially perfused with 200 ml
of 0.1 M phosphate buffer (pH 7.4; PB) followed by 2S0-300 ml of ice-cold 4%
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paraformaldehyde in PB. A 2.5-3.0 cm segment of the spinal cord that included the
transplantation site was removed and post-fixed for 2 hours at 4°C, then transferred to
30% sucrose in O.IM PB for cryoprotection until sectioned. The middle 1 mm segment
of the channel and adjacent spinal cord was cut, fixed in 1% osmium oxide in O.IM
cacodylate buffer, dehydrated, and embedded in epoxy resin. One micron semi-thin
transverse sections were stained with 1% toluidine blue.

The proximal and distal channel-cord segments were sectioned longitudinally on a
Leica cryostat at 20-25 11m and mounted on microscope slides. Sections were rinsed in
phosphate buffered saline (PBS) and blocked and permeabilized in PBS containing 10%
normal donkey serum (NDS) and 0.3% Triton X-IOO for 1 hr at room temperature. They
were subsequently incubated overnight at 4°C in primary antibody containing 5% NDS
and 0.25% Triton X-IOO in PBS. Polyclonal rabbit anti-glial fibrillary acidic protein
antibody (anti-GFAP; 1:100, Chemicon, Temecula, CA) were used to identify astrocytes.
Macrophages were stained using monoclonal antibodies anti-ED 1 (1 :500; Chemicon).
Twenty four hours later, sections were rinsed in PBS and incubated in either fluoresceinconjugated or rhodamine-conjugated Fab' fragment secondary antibodies from donkey
(1: 100; Jackson Laboratories, Baltimore, MD). Slides were washed in PBS, mounted,

and examined using fluorescent microscopy and photographed. Figures were assembled
using Adobe Illustrator® software. Estimation of the relative density of GF AP+ and ED 1+
staining was performed using Scion image software® (Scion Corporation, Frederick,
Maryland).

Stereo logy.
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Stereo logical counting was performed as previously described (Abdellatif et al.
2007). Briefly, 1 !Jm semi-thin toludine blue-stained sections were examined using a
stereology workstation (Stereolnvestigator ®, MicroBrightField, Williston, VT). The
investigator was blinded to the experimental groups of animals. Four-six sections per
animal were counted and the mean calculated for myelinated axons and blood vessels.
The area of tissue cable was determined using 4x objective lens and then divided in
counting frames of 40 by 40 !Jm using the Optical Fractionator probe. Counting was
performed using an oil-immersion objective with a high numerical aperture (100 x,
NA=1.00). Section thickness was measured for every section counted per animal

(~1

!Jm). Total numbers of myelinated axons and blood vessels in the tissue cable were
generated using the StereoInvestigator® software by multiplying the numbers of counted
axons or blood vessels with the sampling probability (see, (Schmitz and Hof2000)
Statistical analysis.
One way ANOVA was used to compare control values with experimental groups
followed by Tukey's post-hoc comparison test. p<0.05 was considered as statistically
significant.
RESULTS
Ad5-D15A SCs optimally enhance axonal regeneration and myelination
We compared the number of myelinated axons, tissue cable area, and the number
of blood vessels in the tissue cable midsection of transplanted PAN/PVC mini-guidance
channels seeded with SCs that were infected ex vivo with pLenti6-D15A, Ad5-D15A, or
LZRS-D 15A, or LZRS-EGFP. The number of myelinated axons was significantly
(p<O.OOI) higher in the Ad5-D15A- SC grafted group (3,334.43 ± 469.01) compared to
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that ofpLenti6-D15A-SCs (1,155.l1 ± 62.92) or LZRS-DI5A-SCs (665.44 ± 125.58)
(Fig.4.1a). All groups had significantly (p<O.OOI) higher number of myelinated axons
compared to the LZRS-EGFP SC-grafted animals (357.29 ±27.96)
The group grafted with channels seeded with pLenti6-Dl5A SCs had significantly
higher (p<O.Ol) tissue cable area (378,556.63 ± 106,168.30

2

)lm )

at the midsection of the

channel (Fig. 4.1 b) compared to all other experimental groups. There was no significant
difference between the Ad5-DI5A SCs (191,,858.75 ± 12,206.47
LZRS-DI5A SCs (170,881.69 ± 67,727.43
40,646.96

2
)lm )

2
)lm )

2

)lm )

and either the

or the LZRS-EGFP-SCs (207,293.36 ±

grafted groups.

The number of blood vessels in the tissue cable at the channel midsection was not
significantly different between Ad5-DI5A (77.5 ± 17.35) and pLenti6-Dl5A (62.13 ±
10.38) SC grafted groups and both had significantly higher (p<O.OI; (\p<O.OOI) numbers
of blood vessels than the LZRS-DI5A SC (38.97 ± 4.37) or LZRS-EGFP SC (13.75 ±
9.20) grafted groups, respectively. The pLenti6-D15A SC grafted animals were
significantly higher (p<O.O 1) than the LZRS-EGFP SC grafted group (Fig 4.1 c).

Transplantation of mini-channels with LZRS-D15A SCs leads to functional recovery
following a thoracic SCI hemisection injury.
For the second part of this study we tested the behavioral effects of transient
versus long term D15A expression by comparing LZRS-DI5A SC and pLenti6-Dl5A SC
grafted rats with those that received LZRS-EGFP SC grafts and sham controls. Animals
were tested on grid walk task and Hargreaves's planter analgesia testing. Animals that
received mini-channels seeded with SC infected with LZRS-DlSA had significantly
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lower (p <0.00 I) numbers of foot falls of the right hind paw (injury side) when compared
to other experimental groups. There was a significant (p<O.O 1) difference between
LZRS-D15A SC and LZRS-EGFP-SC groups. The pLenti6-D15A SC group had
significantly (p=O.Ol) worse performance on the grid task as compared with LZRS-EGFP
SCs group. There was a consistent significant difference (p <0.01) in all experimental
groups between the right and left hind paw foot falls, indicating residual deficits on the
injury side (Fig 4.2a). Hargreaves's planter analgesia testing showed no significant
difference between right and left hind paws within groups or between experimental
groups (Fig 4.2b).
Histological analysis of GF AP+ staining at the graft host interfaces showed no
significant difference in glial scarring between groups (Fig 4.3). There was also no
significant difference in ED 1+ staining, a marker of activated microglial and
macrophages, at the interfaces between groups.

DISCCSSION

Axons normally extend down diffusible gradients of chemo-attractant and chemorepellent molecules during development
Goodman 1996). The use of the closed

(Tessi~~r-Lavigne

semi-p~~rmeable

1994; Tessier-Lavigne and

channel allowed the possibility

of re-creating a gradient following SCI to test the hypothesis that regenerating axons
would similarly follow neurotrophic factor gradients. Previous data showed that D15A
expression from SCs infected with Ad5-D15A-, pLenti6-D15A-, and LZRS-D15A- SCs
and then grafted into the spinal cord had differential expression patterns with retroviral
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expression at levels half of lentiviral or adenoviral expression at I week and downregulating to baseline at 2 weeks. Lentiviral and adenoviral expression levels were
identical at I and 2 weeks, but adenoviral-driven expression dropped significantly lower
than lentiviral driven levels at 4 weeks (Abdellatif, Pelt et al. 2006). The fact that AdS··
D15A- pLenti6-D15A-, and LZRS-DlSA- SC grafts had 9.3X, 3.3X, and 1.9X more
myelinated axons in the tissue cable than LZRS-EGFP-SC grafts suggests that high levels
of neurotrophic factor expression in the SC/channel are necessary early during axonal
ingrowth but that sustained high levels of neurotrophins are detrimental for those axons
to be myelinated. That the pLenti-6D15A-SC grafts had twice the tissue cable area than
the other groups would further support the contention that continued axonal ingrowth
and/or sprouting is maximal in the high neurotrophin environment. However, electron
microscopic analyses would be needed to conclusively determine if the greater tissue
cable size reflected increased numbers of unmyelinated axons or enhanced survival of
grafted SCs.
Previously, Xu et al. (1995) showed that the infusion of a combination ofBDNF
and NT3 into the SC-grafted channel leads to significantly higher number of myelinated
axons when compared to SC-vehicle groups. Although the infusion of BDNF and NT3
into to the distal spinal cord parenchyma had no significant effect on axonal numbers
within the channel, it led to enhanced axonal re-entry into the cord tissue for up to 6 mm
(Bamber, Li et al. 2001).
Present data show that viral-mediated delivery of D 15A leads to better outcome
compared with protein infusion ofBDNF and NT3. This may be due to better biological
availability of the expressed protein to targets within the channel environment. SCs
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grafts alone lead to regeneration of mainly propriospinal axons into the graft and only
when BDNF and NT3 were infused into the channel were supraspinal axons seen in the
graft (Xu, Guenard et al. 1995). Some of these regenerating axons were from raphe
nucleus and two thirds ofaxons originated from spinal and lateral vestibular nuclei.
Previous data show that in SC only grafts there are about 8 time more
unmyelinated axons within the tissue cable than myelinated ones (Xu, Guenard et al.
1995; Xu, Chen et al. 1997; Golden, Pearse et al. 2007). When SCc infected with LentiD15A or Adeno-Dl5A were transplanted 1 week post injury, the ratio of myelinated
axons to unmyelinated ones changed to I: 1 (Golden, Pearse et al. 2007). This may be
due to the increase in myelination of regenerating axons or the absence of unmyelinated
axons within the graft area because of the inhibitory effect of high concentration ofD15A
within the graft environment.
Neurotrophin expression also increased blood vessel number, with no differences
between the Ad5-DI5A and pLenti6-D15A SC grafted groups, but twice what was
observed in LZRS-D15A-SC and 5-fold higher than EGFP-SC grafted animals. Recent
data has implicated BDNF as a regulator of angiogenesis (Kermani and Hempstead 2007)
and neurotrophins may interact with other angiogenic factors such as VEGF (Ando,
Kaneko et al. 2004). Present data would suggest that neurotrophin treatment after SCI
may be a novel therapeutic approach to maintain vascular homeostasis which is disrupted
after SCI (Casella, Marcillo et al. 2002; Loy" Magnuson et al. 2002). Importantly, there
may be different optimal concentrations of exogenous genes that facilitate axonal growth
and/or maintenance and those that are optimal for revascularizationlvascular stabilization.
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As both are likely necessary for long term maintenance of regenerating CNS tissues, this
may be problematic when designing therapeutic strategies.
Histological evaluation indicated no effect on the astrocyte reaction at either
graft-host interface. There was no difference in ED 1 immunoreactivity between all
experimental groups indicating that the release of neurotrophins from SCs inside the
mini-channel did not alter the host tissue response, at least at this early level of analysis,
in a manner that could affect axonal regeneration at least as indicated by the two
parameters chosen in this study.
Functionally, the pLenti6-DI5A-SC group made significantly more stepping
errors on the grid than did the LZRS-D15A SC grafted group, the latter of which were
significantly different from EGFP-D 15A-SC animals. High D 15A levels in the channel
may affect distal sensory neurons that influenced hind limb locomotor reflex circuits. If
the former postulation is accurate, it raises a cautionary concem that altering neuronal
function in the context of SCI may ultimately prove to be functionally detrimental.
One confounding variable in the present experimental design is the fact that no
physiological impetus was given to the regenerating/sprouting axons, either ascending or
descending, to exit the channel graft. High D 15A levels may actually retard axons from
entering spinal cord parenchyma. The creation of a rapidly down regulating transgene
expression zone inside the channel that is followed by an increasing concentration of
neurotrophins in the spinal cord parenchyma may further enhance the exit ofaxons from
the channel environment and into the cord tissue. Previously, pump infusion ofBDNF
and/or NT3 at the distal end of the channel in the spinal cord parenchyma had no effect
on the number of myelinated axons in the tissue cable formed inside the mini channel
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following transplantation (Bamber, Li et al. 2001). However, this study showed that the
infusion of these neurotrophins enhanced axonal re-entry into the distal host spinal cord.
More recently, Ramer et al (2000) showed that in adult rats with injured dorsal
roots, treatment with, NT3 but not BDNF, resulted in selective regrowth of damaged
axons across the dorsal root entry zone and into the spinal cord. Only animals treated
with NGF and GDNF recovered sensitivity to noxious heat and pressure. This clearly
indicates the selective nature of neurotrophins on distinct subpopulations of sensory
neurons.
Temporally and spatially regulating transgene expression specific for defined
populations of ascending sensory and descending motor axons, as well as controlling
effects on neovascularization and inflammatory responses, poses a daunting challenge to
em~ctively

use exogenous transgenes to facilitate SCI repair. It is only through thorough

investigation of combinatorial therapeutic effects on individual effectors systems that
rational therapeutic strategies can be devised.
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Table 4.1: Animal groups used for the comparison of different viral delivery vectors.
group

Thoracic Hemisection & trans plantation of
a SC- channel seeded wi th SC~ infected
with virus

testing

6

Ad5-D15A-SC

NA

6 weeks

10

LZRS-DI5A-SC

4-6 weeks

6 weeks

13

pLenti6-D15A-SC

4-6 weeks

6 weeks

8

LZRSEGFP-SC

4-6 weeks

6 weeks

6

Naive rats for behavior

4-6

NA

n

Behavioral

Sacritice

-"

1

2"
-"

3
-"

4
-"

5

'--"
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Figure Legends
Figure 4.1. a. Stereological assessment of the number of myelinated axons, showed

significantly (p<O.OOI) higher number of myelinated axons in Ad5-DI5A- SC group
(3,334.43 ± 469.01) compared to pLenti6-D15A-SC group (1,155.11 ± 62.92) and LZRSD15A-SCs group (665.44 ± 125.58). All groups had significantly (p<O.OOI) higher
number of myelinated axons compared to the LZRS-EGFP Sc.·grafted animals (357.29
±27.96). b. Measurement of the cross section area of the tissue cable at the channel
midpoint showed that pLenti6-D 15A SCs group had significantly (p<O.O 1) bigger tissue
cable compared to all other experimental groups. There was no difference between the
AdS-D1SA SCs and either LZRS-D1SA SCs or the LZRS-EGFP-SCs groups. c.
Counting the number of blood vessels in the midsection of tissue cable no significant
difference between Ad5-DI5A and pLenti6-D15A SC groups. Both groups were
signifiicantly higher than the LZRS-DI5A SC (p<O.OI) and LZRS-EGFP SC (p<O.OOl)
groups. The pLenti6-D1SA SC group was significantly higher (p<O.OI) than the LZRSEGFP SC grafted group. Data shown as mean ±SD (**=p<O.OI, ***=p<O.OOI)

Figure 4.2 a. Comparison of foot falls on grid walking test showed significantly lower

numbers of foot falls of the right hind paw (injury side) (p <0.001) in animals receiving
mini-channels seeded with SC infected 'with LZRS-DI5A when compared to all other
groups. The pLenti6-Dl5A SC group was significantly (p=O.OI) worse as compared with
LZRS-EGFP SCs group. There was significant difference (p <0.01) in all experimental
groups between the right and left hind paw foot falls. b. Testing the latency of hind limb
withdrawal in response to heated light stimulus on Hargreaves's planter analgesia testing
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apparatus showed no significant difference between right and left hind paws within
groups or between experimental groups . Data shown as mean :f:SD, (** =p<O . OI,
***=p<O.OOI ).

Figure 4.3. Relative density of ED 1+ staining and GF AP+ staining was estimated using
Scion image software® (Scion Corporation, Frederick, Maryland) at both rostral and
caudal graft host interfaces. Three sections per animal were used for estimation. ED 1+ at
the rostral and caudal graft host interfaces was not different between all tested groups.
There was no difference of GF AP+ staining at either distal or proximal graft host
interfaces between all experimental groups. Data shown as mean ± SD.
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Figure 4.1
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CHAPTER 5

DIISCLJSSJON

Immediately following spinal cord injury (SCI), acute hemorrhage of the injury
site occurs. This is followed by a transient macrophage infiltration which clears necrotic
tissue. Subsequent scarring occurs at the primary injury site. What makes the healing
process of the eNS unique is the secondary damage that occurs to local, as well as
distant, neurons as a result of the primary injury to their axons at the initial damage site.
The current consensus is that CNS repailr strategies should aim at one or more of the
following:
•

Controlling the initial injury and inflammation.

•

Preventing both local and distant secondary cell death.

•

Altering the glial reaction/scarring to create a more favorable environment for

axonal regeneration.

•

Promoting axonal regeneration and enhancing myelination of both spared and

regenerating injured axons.

Repair of the damaged spinal cord is a complicated task that will require the right
combination of factors to address one or more of the above mentioned points to achieve
neuronal protection, axonal regeneration, myelination, and eventually functional
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recovery. Neurotrophins, cellular transplants, and tissue bridges or bio-scaffolds to help
axons cross the scarred area, are a few examples of possible therapeutic approaches. In
recent years, a variety of those proposed therapies, either singly or in combination, have
led to variable functional improvement in rats and mice.
The "tissue engineering" approach proposed here utilizes a bio-material bridge
(here" 60:40 PAN/PVC mini-channel) which provides a milieu in which the cellular
scaffold can be directed. The channel provides an in vivo environment in which to
examine cell proliferation, migration, survival and maintenance of phenotype as well as
cell-axon interaction following injury and regeneration. Biomaterials used in
regeneration studies should have certain favorable characteristics including large surface
area, large pore size, and the ability to modulate the organization of the cells and the
extracellular matrix derived from them (Atala 2005; Zhang, Yan et al. 2005). Early
attempts at providing a favorable tissue bridge utilized peripheral nerve segments to
bridge complete SCI transaction lesions (Richardson, McGuinness et al. 1980), a concept
that dates back to the early work of Ramon y Caja1 (1928) which led him to speculate
that if the environment is favorable CNS axons are able to re-grow.
The work presented here is an effort to test and provide a suitable combination of
neurotrophins delivered using viral vectors, combined with celliular transplantation and a
biomaterial bridge to cross the injury gap following an experimental thoracic SCI in adult
rats. Our work builds on the previous success in transplanting SC-seeded mini channels
in a spinal cord hemisection model (Xu" Gue:nard et al. 1995). These previous
experiments illustrated that the transplanted SCs enhance regeneration ofaxons and
myelinate regenerating axons when transplanted inside a polyacrylonitrile/poly-
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vinylchloride (PAN/PVC) mini-channel into the hemisected thoracic cord. Although the
hemisection model is not clinically relevant, it offers the chance for testing different
therapeutic approaches in the mini-channel environment as well as test the interaction of
the cellular graft with the host spinal cord at both distal and proximal graft-host
interfaces.
Transplantation strategies for SCI aim at enhancing regeneration of severed
axons, effective myelination of regenerating axons as well as demyelinated intact axons,
and changing the post-SCI local environment in a favorable way to allow regenerating
axons reach their potential targets. The approaches that have been used include the
delivery ofneurotrophins or other neuronal survival enhancing molecules (e.g. cAMP,
(Pearse, Pereira et a1. 2004), extracellular matrix modulators (e.g. chondroitinase ABC;
(Bradbury, Moon et a1. 2002; Barritt, Davies et a1. 2006), or the provision of physical
bridge to help regenerating axons cross the injury gap (Xu, Chen et a1. 1997; Teng, Lavik
et a1. 2002). Several cell types have been investigated as possible candidates for use in
transplant-mediated SCI repair with variable success. Examples of these cell types
include fibroblasts, whether naive or genetically modified to secrete neurotrophic factors
or matrix metalloproteases (Dekker, Winkler et a1. 1994; Emerich, Hammang et a1. 1994;
Tuszynski, Peterson et a1. 1994; 1996; Franzen, Martin et al. 1999; Frechilla, lnsausti et
a1. 2000; Tobias, Shumsky et a1. 2003; Pizzi and Crowe 2006), neural stem cells (Cao,
Zhang et a1. 2001; Nakamura and Toyama 2003; Okano, Ogawa et a1. 2003), bone
marrow stromal cells (Sykova, Jendelova et a1. 2006), oligodendrocyte precursor cells
(OPCs) (Keirstead and Blakemore 1999; Cao, Xu et a1. 2005), olfactory ensheathing glial
cells usually referred to as OECs, OEGs or OEGCs (Heredia, Gascuel et a1. 1998; Li,
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Field et al. 1998; 1998; Ramon-Cueto 2000; 2000), astrocytes (Davies, Huang et al.
2006; Love 2006), and SCs (Xu, Guenard et al. 1995; Xu, Chen et al. 1997; Xu, Zhang et
al. 1999). These cells were also tested in various combinations of OECs and stem cells
(Ao, Wang et al. 2007), OECs and SCs (Fouad, Schnell et al. 200S; Pearse, Sanchez et al.
2007), stem cells and SCs (Zeng, Ding et al. 200S). When SC were compared to OECs
after a more clinically relevant contusion SCI (10 gm, 12.S mm NYU impactor), SC
grafted animals showed more myelinated axons than those that received OEC, with
significant improvement in hind limb function in SC group (Takami, Oudega et al. 2002).
Following transplantation, SCs remyelinate demyelinated axons (Li and Raisman
1994) and enhance regeneration (Tuszynski, Weidner et al. 1998). However, the
interaction of SCs with astrocytes may limits their usefulness ill1 CNS repair (Franklin and
Barnett 1997), as SCs do not to co-exist with astrocytes (Lal, Ghirnikar et al. 1996;
Lakatos, Franklin et al. 2000; Shields, Blakemore et al. 2000). This potential problem
can be solved by altering the cell adhesilon properties of SCs, e.g. with a retroviral vector
encoding sialyl-transferase X to express polysialic acid (PSA) IOn the naturally present
neural cell adhesion molecule (NCAM), leading to better integration with astrocytes in

vitro and better functional recovery in vivo (Papastefanaki, Chen et al. 2007).
While the therapeutic potential of any cell type used for grafting in SCI is
essential, it would be optimal to be able to obtain the relevant tissue from the patient to
enable autologous transplantation. This would avoid tissue rejection and the need for
immune suppressive therapy. Therefore, the use of human astrocytes, OPCs, or OECs in
SCI would require heterologous grafting as it would be difficult to obtain the tissue from
SCI patients. We contend that at present, SCs are one of the most clinically relevant cell
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types for use in SCI repair as they can be autologously obtained. Therefore, we chose
SCs as a cellular graft in our combination strategy. Although currently we are still far
from achieving clinically acceptable success, SCs offer an excellent source of autologous
cells that can be easily harvested from the SCI patient, purified and grown in culture and
transplanted back into the same donor thus eliminating the need for immune suppression
following transplantation. SCs can be harvested from peripheral nerves that will not lead
to significant functional deficit in humans (e.g. sural nerve) that are commonly used for
other clinical applications such as facial nerve repair, SCs can also be harvested from
skin (Biernaskie, Sparling et ai. 2007).
Axonal failure to exit SC grafts can be attributed to many factors including the
lack of interaction between SCs and astrocytes, higher expression of neurocan,
phosphacan, and NG2 are expressed near the: rostral and caudal graft host interfaces with
higher concentrations of phosphacans at the caudal graft-host interface (Plant, Bates et ai.
2001). This phenomenon has been also observed in grafts of neural stem cells expressing
NT-3 (Lu, Jones et al. 2003). Even when OECs grafts were combined with a SC bridge
and chondroitinase ABC infusion (Fouad, Schnell et al. 2005), there was signifilcant
functional improvement, although no corticospinal or rubrospinal fibers crossed the graft
and only some regenerating serotonergic fibers did. Axons normally extend down
diffusible gradient during development {Tessier-Lavigne 1994). The lack of motivation
for axons to exit the new graft permissive environment and re-enter the host spinal cord
may be due to the cellular graft itself as it may offer regenerating axons a more favorable
environment with little or no motivation for the axons to exit and re-enter the spinal cord
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parenchyma. We hypothesize that the creation of a gradient of neurotrophins may lead to
enhanced axonal regeneration and re-entry into the spinal cord tissue.
We here report the initial success of creating such a gradient and provide evidence
of functional recovery following transplantation of SC infectedl with retrovirus expressing
DISA.

f-x vivo retroviral LZRS-DISA delivery leads to transient expression of the

trans gene within the channel environment. Although we found a significantly lower
number of myelinated axons in the retrovirus group when compared with lentivirus,
functional recovery was significantly better in the retrovirus group. A possible
explanation for this phenomenon would be that different patterns of trans gene expression
within the channel environment lead to recruitment of different populations ofaxons.
Alternatively, the high sustained neurotrophin levels may detrimentally affect hindlimb
circuitry by affecting ingrowing (regenerating and/or sprouting) sensory axons.
Recently, Hill and colleagues (2007) found an 80% reduction in SCs numbers
within I week post transplantation after contusive SCI. Death of transplanted cells by
necrosis and apoptosis is not unexpected, as SCs survive poorly within the contused
spinal cord environment and delayed transplantation only improved survival minimally
(Hill, Moon et al. 2006). This may explain the modest improvement in functional
recovery encountered in our hand as well as with others (Takami, Oudega et al. 2002).
Hill and colleagues (2006) used labeled SCs from human placental alkaline phosphatase
(hP AP) transgenic rats to assess SC survival in a spinal cord contusion lesion. Few hP AP
SCs survived and delaying transplantation for 7 days was followed by a second wave of
cell death after surviving SCs had integrated into the spinal conl Immunosuppression
with cyclosporine combined with delayed transplantation resulted in the best survival. A
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very interesting finding was that in all cases extensive infiltration of endogenous p7S+
SCs into the injury site suggested that endogenous SCs may play an important role in the
repair observed after SC transplantation. Interventions to enhance the survival of SCs
may be necessary to achieve better functional recovery. The exposure of SCs to the
spinal cord environment in contusion model may explain the massive reduction in cell
numbers which may not be the case when SCs are transplanted in an enclosed semiisolated environment within the mini-channel. However, diffusible signals from the
injured cord may still cross the channel wall and affect SCs survival. We cannot confirm
whether or not endogenous SCs may be a contributing factor in the behavioral recovery
observed following transplantation of LZRS··O ISA infected SCs.
The interactions between SCs and neurotrophins are significant to our findings
that myelinated axons numbers do not correlate with functional recovery. In this study,
we used OISA, a bi-functional molecule with both BDNF and NT-3 activities. There
seems to be significant competition between the two neurotrophins with regards to SC
function. BDNF enhances myelination through p7S

NTR

and inhibits migration (Cosgaya,

Chan et al. 2002; Yamauchi, Chan et al. 2(04). In contrast, NT-3 enhances migration and
inhibits myelin formation through TrkC receptor (Cosgaya, Chan et al. 2002; Yamauchi,
Chan et al. 2(03). It remains to be seen whether the combination ofBDNF and NT-3
leads to conflicts in signaling pathways that leads to SC dysfunction or a differential
response where myelination or proliferation takes the upper hand.
SCs play an active role in supporting neuronal outgrowth after injury by
producing significant amounts ofNTFs such as NGF (Heumann 1987), BDNF {Meyer,
Matsuoka et al. 1992), PDGF (Eccleston, Collarini et al. 1990) and CNTF (Friedman,
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Scherer et a1. 1992). The levels of NTFs produced from both transplanted and
endogenous SCs may be another significant contributing factor in re-organizing local
circuitry within the spinal cord leading to the functional improvement noted in our study.
The second step of creating a gradient is the provision of an increasing
concentration of neurotrophins in the spinal cord parenchyma at the graft host interface.
We show in Chapter 2 that increasing the titer of the injected virus significantly increases
the concentration of the transgene at the: injection site. Ongoing work is examining the
effect of creating an increasing gradient of neurotrophins at the proximal graft host
interface. Previous data (Taylor, Jones et a1. 2006) show that although such gradients are
successful in axonal bridging beyond the lesion, growth for longer distances is not
sustainable with a trophic stimulus. Other factors may be needed to enhance axonal
growth over longer distances to enable these injured axons to reach their targets.
The angiogenic response following SCI is an important element of injury and the
restoration of a functional vascular bed lis important to recovery of function. A change in
the microvasculature of the spinal cord after contusion inj ury is essential for the spinal
cord to undergo self-repair (Loy, Crawford et a1. 2002; Hagg and Oudega 2006). We
here show significant increase in the number of blood vessels in the tissue cable
following LentiD 15A and Adeno 0 15A use within the channel. Although the functional
integrity of these blood vessels cannot be verified we believe that these vessels are an
essential component of the tissue cable success in bridging the injury gap and supporting
axonal growth and myelination. The use of D 15A seems to enhance angiogenesis
significantly. Moreover, prolonged expression of 0 15A seems to enhance
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vascularization significantly more than transient expression following LZRS- 0 15A
retrovirus.
The use of viral gene delivery in a clinical setting is still in the early stages. Many
viral options are available for use in SCI research. Some have the advantage of being
used both in vitro and in vivo the use of adenovirus is complicated by the intense immune
response it elicits in the CNS tissue (Abdellatif, Pelt et a1. 2006). Viral vectors do not
initiate an intense inflammatory reaction indude lentivirus, adeno-associated virus
(AA V) and Herpes simplex virus (HSV) (Tyler and Federoff2006; Tyler, Wuertzer et a1.
2006; Kitamura, lwanami et a1. 2007). Other viral vectors including lentiviral variants
including feline immunodeficiency virus have been also employed in eNS research. Until
safely issue and immune response reach an acceptable level for human trials, the use of
many of these viral vectors may be limited to experimental models for the time being.
The use of viral gene therapy have been complicated by many factors that affect
the outcome. In cystic fibrosis (Alton, Geddes et a1. 2000; Alton 2007), the use of
adenoviral delivery has led to a transient gene expression where perhaps a long term
expression would have more appropriate. In another unfortunate complication of intrahepatic injection of E 1IE4 deleted adenoviral vector to treat ornithine transcarbamylase
OTe deficiency, has led to the death of an 18 year old patient as a complication of the

inflammatory response of the liver to the injected virus. However, this was likely a death
related to a much too high viral dose. These trials with variable outcomes make it
difficult for SCI research to take the risk and proceed to human studies using viral
vectors. We believe that as the safety and efficiency of viral delivery become more
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clinically acceptable, it will be more appropriate to use viral delivery methods in clinical
SCI research.
For the spinal cord injured patient, complete sensory and motor recovery is a
dream that may take more than one's life time to achieve. In the mean time, quality of
life improvement may be a reachable goal. Recovery of bladder and bowel control,
regain of sexual function, and treatment of autonomic dysreflexia are a few examples of
what may be a more realistic approach to target rather than locomotion. Eventually,
return to the pre-injury level of function wOUlld be the ultimate goal for these patients.
However, for now researchers can and will approach SCI as a complicated pathology that
can only be tackled as small pieces of an extremely complex multifaceted puzzle.

It is my vision that a combination strategy will be the answer for human spinal
cord injured patients. I suggest that one feasible approach would be a combination of
SCs (or maybe an alternative cell type) with a cocktail of neurotrophins delivered using
viral mediated delivery in vivo and/or ex vivo and extracellular matrix modifying agents
that will be then surgically applied at the center of the injury. Such an approach would
take weeks to expand cells collected from the patient and have them modified to secrete
the specific neurotrophins or other molecules. It is thus extremely critical to develop
successful approaches to decrease the secondary injury and prevent further damage to
local as well as distant axons and neurons, to prepare the local injury site for the
definitive therapeutic "mix". I am confident that there will be a cure for SCI, I may not
live long enough to see that happen, but I am glad that I had a chance to take a step
forward in this thousand mile road and I wish that this work will benefit future research
and help achieve that dream.
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APPENDIX

LIST OF ABBREVIATIONS

ANOVA

analysis of variance

APC

Adenopolyposis coli, oligodendrocyte antigen

BDNF

brain derived neurotrophic factor

CNS

central nervous system

CNFT

Ciliary Neurotrophic factor

CSF

cerebrospinal fluid

CSPG

chondroitin sulfate proteoglycan

CST

corticospinal tract

DC

dorsal columns

GFAP

glial fibrillary acidic protein

IP

intraperitoneal

NeuN

neuronal antigen

NF-H

neurofilament (210 kDa)

NGF

nerve growth factor

NT-3

neurotrophin 3

NT-4

neurotrophin 4

PB

phosphate buffer

123

PBS

phosphate bufD~red saline

SC

Schwann Cell

SCI

spinal cord injury

SMI31

neurofilament antigen

TBS

tris buffered salline

TNF

tumor necrosis factor

~III

neuronal antigen

tubulin
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